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                                                 ABSTRACT 
BACKGROUND AND OBJECTIVES: 
The responsibility of the Anaesthesiologist in obstetrics is arguably greater than 
in any other fields of anaesthesia. The aim of the study is to compare the quality 
of epidural analgesia of 0.125% bupivacaine with 0.1% ropivacaine after 
intrathecal administration of fentanyl 25 mcg in combined spinal epidural 
labour analgesia. 
METHODOLOGY: 
     Approval was obtained from the Institutional Ethical Committee board. This 
comparative clinical study of combined spinal epidural labour analgesia for 
vaginal delivery with intrathecal fentanyl 25 μg initiated in all parturients 
followed by group B receives epidural 0.125% bupivacaine 10 ml with 2μg of 
fentanyl/mL and group R receives epidural 0.1% ropivacaine 10 ml with 2μg of 
fentanyl/mL  was conducted in 60 term healthy primi gravida with cephalic 
singleton pregnancy with 30 in each group, who wished and opted for painless 
labour after obtaining informed risk consent. Two groups were compared in 
terms of quality of analgesia using VAS, patient satisfaction, onset and degree 
of motor & sensory blockade, vitals, fetal heart rate changes, duration of labour, 
mode of delivery, neonatal outcome and side effects of the drugs. 
 RESULTS: 
Both groups were comparable in age, height, weight, parity and time of 
initiation of labour analgesia. Combined spinal epidural analgesia decreases the 
duration of labour. Patient satisfaction, level of sensory blockade, mode of 
delivery, duration of labour, neonatal outcome and complications are 
comparable. 
 Quality of analgesia was excellent in both the groups. Out of 60 parturients, 10 
patients (33.3%) in group B and 4(13.3%) patients in Group R had grade 1 
Bromage (minimal) motor blockade.  P value (0.67) which was statistically 
insignificant. Maximum motor blockade (grade 1 Bromage) has occurred during 
the first stage of labour and was seen immediately following the first epidural 
bolus dose that doesn’t affect the progression of labour.    
CONCLSION: 
The observation of this study shows that both bupivacaine 0.125% and 
ropivacaine 0.1% administered epidurally as a part of combined spinal epidural 
technique provides equal and effective quality of analgesia.  Motor blockade of 
grade 1 Bromage was seen relatively more bupivacaine group but that was not 
statistically significant, it needs further studies in larger scale. 
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                                   INTRODUCTION 
“The delivery of the infant into the arms of a conscious and pain free mother is 
one of the most exciting and rewarding moments in medicine” 
                                                                                        -MOIR DD  
Labour is defined as events that occur serially in female genital tract in 
order to expel the products of conception out of the womb into outer world 
through the vagina1. 
Pain relief in parturient has always been surrounded by myths and 
conflicts. Hence, achieving an excellent and safe analgesia during labour 
remains a most challenging issue. 
History of obstetric anaesthesia began with James Young Simpson, who 
administered Ether to a woman with deformed rachitic pelvis in 1847.She 
survived the complicated delivery absolutely free of pain .But his concept of 
“Etherisation of labour” was condemned strongly by critics and was not 
accepted on the basis of religious background2 .Religious debate continued till 
1853, when John Snow administered chloroform to Queen Victoria during her 
eighth child birth, Prince Leopold.3 
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In 1950, Neuraxial techniques were introduced for labour pain relief and 
during the past two decades3, many more recent advances lead to 
comprehensive and evidence based management of labour pain. 
Labour is a very painful process4. It represents the most common acute 
severe pain in adult life. In McGill pain questionnaire, labour pain ranks in 
between cancer pain and Amputation of digits5.  
 
  
 
 
 Fig1: McGill Pain Questionnaire 
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Progression of labour, maternal and foetal well being may be affected by 
physiological response to labour pain6. 
• Maternal stress response to pain leads to increase in corticotrophin, 
cortisol, nor epinephrine and epinephrine levels6. 
• Increased nor epinephrine levels will reduce uterine blood flow by 35-
70%.6 
• Epinephrine has relaxation effect on uterus which may prolong the 
labour. 
• Catecholamine’s increases maternal cardiac output, increased systemic 
vascular resistance and oxygen consumption.6 
• Hyperventilation during contraction increases the work of breathing , 
oxygen consumption and resulting in hypoxia which reduces the utero 
placental blood flow by up to 25%.7 
• Respiratory alkalosis shift oxyhemoglobin dissociation curve to left and 
fetal Pa02 may fall up to 23%.7 
• Compensatory metabolic acidosis appears to be transferred to the fetus. 
•  There is delayed gastric and urinary emptying.8 
• Effective pain relief attenuates all these detrimental of stress response to 
labour pain.  
• A goal of maternal labour analgesia is effective pain relief without 
compromising progression of labour, maternal and fetal safety. 
4 
 
 
 
 
 
Fig 2: Effects of Labour Pain 
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Various techniques available for labour analgesia 9includes 
 
 
 
 
 
 
 
Amongst all, Neuraxial techniques remain the gold standard to provide effective 
pain relief and least depressant method in current clinical practice. 
• Regional technique avoids the risk of gastric aspiration , avoids the usage 
of general anaesthetic drugs and allows mother to remain awake and 
participate during delivery. 
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• It has been said that women confined to bed during labour  is associated 
with prolonged labour due to  abnormal presentation,  fetal distress that 
results in increased instrumental deliveries.10 
• Epidural analgesia remains the most commonly used technique. Time for 
onset of action takes up to 20 minutes11, 12, 13. But the rapid and reliable 
onset of prolonged analgesia resulting from intrathecal injection with 
greater flexibility and longer duration of epidural technique makes 
combined spinal epidural analgesia superior and ideal technique of choice 
for labour pain. 
• Combined spinal epidural technique is frequently used nowadays because 
of rapid onset of analgesia and better maternal satisfaction. It is 
associated with shortened labour and increased rate of cervical 
dilatation.14 
• Numerous  intrathecal intervention are available by using  combined 
Local anaesthetic agent and opioid or opioid alone or null CSE (dura 
puncture created without injecting any drugs)15 
In this study, we used fentanyl 25mcg intrathecally in both groups to 
provide rapid effective analgesia and then epidurally we used 0.125% 
bupivacaine with fentanyl µg/mL in Group B  and 0.1% ropivacaine with 
fentanyl 2µg/mL in Group R to compare the quality of analgesia. 
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AIM OF THE STUDY: 
         The aim of the study is to compare the quality of epidural analgesia of 
0.125% bupivacaine with 0.1% ropivacaine after intrathecal administration of 
fentanyl 25 mcg in combined spinal epidural labour analgesia. 
 OBJECTIVES: 
Primary Objective: 
 
 To compare the quality of analgesia during the labour in both the 
groups. 
 Secondary Objective: 
 To compare onset, degree and duration of sensory blockade in both 
the groups. 
 To compare onset, degree and duration of motor blockade in both 
the groups. 
 
 To compare the rate of cervical dilation duration and progression 
of different stages of labour and mode of delivery in both the 
groups. 
 
 Intrapartum fetal heart monitoring and newborn evaluation with 
APGAR score. 
 
  To study the side effects of the drugs and procedure. 
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REVIEW OF LITERATURE: 
ANATOMY OF EPIDURAL SPACE: 
It is a potential space within the bony cavity of spinal canal and lies outside the 
dural sac .It extends vertically from foramen magnum to coccyx and 
communicates with paravertebral space laterally through intervertebral 
foramen.16 
Boundaries: 17 
Anteriorly Posterior longitudinal ligament and intervertebral disc 
Posteriorly Ligamentum flavum and the periosteum of the laminae 
Superiorly  Foramen magnum where the periosteal and spinal layers 
of dura fuse together 
Inferiorly  Sacrococygeal ligament 
Laterally  The pedicles and the intervertebral foramina containing 
the nerves 
 
 
Fig 3: Epidural Space 
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Contents of the epidural space: 18 
1. Semi liquid fat. 
2. Loose areolar connective tissue. 
3. Arteries – anterior and posterior spinal artery. 
4. Spinal nerve roots. 
5. Extensive venous plexus – Bateson’s plexus of veins. 
Epidural Space in Pregnancy: 
 Epidural space is at a distance of about 4-5 cm from skin in lumbar 
region19 
 Hormonal changes affect vertebral ligamentous structure makes 
Ligamentum flavum feel softer.20 
 Widening of pelvis results in head down tilt of pelvis especially in lateral 
position which greatly affects the spread of drugs.21 
 Epidural veins are engorged and dilated as a result of gravid uterus and 
thus reducing the volume of epidural space. The local anesthetics will 
spread more extensively and hence reducing the dose requirement is 
necessary.  
 Pressure of epidural space in lumbar region is increased from -1cm H2O 
to 4-10 cm H2O in pregnancy.16,18 
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Site of Action of local anesthetics in the epidural space: 18 
When local anesthetics is injected into epidural space, it exerts it action via 
 On nerve roots in epidural space. 
 On nerve roots in subarachnoid space after drug diffusion across dura. 
 On nerve roots in paravertebral space after they have shed their dural 
sheath.  
MECHANISM AND PATHWAY OF PARTURITION PAIN: 
Pain sensation is carried from periphery by small ‘A ‘delta and C fibres, 
the cell bodies of which lie in dorsal root ganglion. From dorsal horn, 
projections enter gray mater22. Except for few ‘A’ delta fibres that relay in 
Lamina I (marginal layer), reminder all synapse in Lamina II (Substantia 
Gelatinosa) and also communication with interneurons whose cell bodies lies in 
LaminaV. Increased activity in these neurons will result in impulse transmission 
along anterolateral ascending column. These neurons respond to low sensitivity 
stimuli like touch and high sensitivity stimuli like pain. 
In response to painful stimuli, Substance P in cell bodies of dorsal horn 
gets released into substantia gelatinosa. Substance P acts as a neuro transmitter 
which gets inhibited by activity of interneurons in Lamina II. These neurons are 
activated by collaterals from large sensory fibres and also by inhibitory fibres in 
dorsolateral funiculus. 
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Stimulation of opioid receptor in substantia gelatinosa and inhibitory 
neurons produces analgesia by reducing cyclic AMP levels in opioid sensitive 
cells, presynaptic inhibition of release of substance P and hyperpolarisation of 
dorsal horn neurons. Opioids are more effective in blocking activities produced 
by ‘C’ fibres than ‘A’ delta fibres. 
Sensory supply: 
Sensations from uterine body are carried out by visceral afferents via 
sympathetic fibres through pelvic inferior hypogastric plexus, uterine plexus 
and Frankenhauser’s plexus. Then these impulse travels to superior ,middle 
hypogastric plexus and aortic renal plexus to enter lower thoracic and lumbar 
sympathetic chains to communicate with T10, 11, 12& L1 spinal nerves. They 
finally pass through posterior roots of nerves to synapse with dorsal horn via 
LaminaV. 
Sensory stimuli from cervix and upper vagina pass through pelvic plexus 
along pelvic parasympathetic nerves to S2, 3, 4 (sacral segments) of spinal cord. 
Sensations from lower vagina pass through internal pudendal nerve. Branches 
of ilioinguinal (L1), posterior cutaneous nerve of thigh (S2,3) and genital branch 
of genitofemoral nerve(L2,3) carry impulse from perineum and labium majora. 
Ovarian plexus also carries afferent impulse from uterus along uterine vessels23. 
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Motor nerve supply: 
Sympathetic fibres from lower thoracic and lumbar segments passes 
through the aortic renal plexuses, superior and middle hypogastric plexus and 
continues as paracervical plexus on each side of cervix. Parasympathetic fibres 
arise from sacral segments and join pelvic plexus. 
Uterine activity is predominantly under hormonal and humoral control. 
Regulation of uterine activity in labour by motor nerve supply is doubtful. 
Severe hypotension caused by widespread sympathetic block may affect the 
uterine activity by hindering hormonal supply.23 
 
STAGES OF LABOUR: 24 
Progression of labour divided into three stages.  
• Stage – I  ( Onset of uterine contraction to full dilatation of cervix). 
• Stage – II (full dilatation of cervix to the delivery of fetus). 
• Stage – III (delivery of placenta and membranes). 
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FIRST STAGE: 
Stage begins with onset of regular uterine contractions and ends with the full 
dilatation of cervix. Average duration in primigravida is 10-13 hours and in 
multigravida is 6-8 hours. 
First stage is further divided into Latent and Active phase. 
• Latent phase (initial 3cm dilatation of cervix) is prolonged in nullipara(8 
hours) than multipara (4 hours) 
• Active phase- Early active phase (cervical dilatation from 3cm to 7 cm) 
and late active phase (from 7 cm dilatation to full dilatation of cervix), 
normal rate of dilatation is 1-2 cm/hour in primi and 1.5 cm/hour in 
multipara. It is considered as prolonged, if rate of cervical dilatation is 
<1cm/hour. 
• Pain in first stage is due to lower uterine distension, mechanical dilatation 
of cervix and stretching of nociceptive afferents resulting from 
contraction of uterine musculature. The intensity and duration of 
contraction correlates with the severity of pain. 
• An afferent nerve fibres accompanying sympathetic nerves in the uterine 
and cervical plexuses, the superior, middle and inferior hypo gastric 
plexuses supplies the uterus and cervix. 
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• Small unmyelinated ‘C’ fibres transmit the pain sensation to dorsal nerve 
roots of T10, 11, 12, and L1 to synapse in the dorsal horn via lower thoracic 
and sympathetic chains. 
Labour pain in first stage is from T10-L1 dermatomes. 
SECOND STAGE: 
From full dilatation of cervix to the delivery of foetus. 
Average duration is one hour in primi and thirty minutes in multipara. 
Prolonged second stage is when the duration is more than 2hours in multipara 
and more than3 hrs in nullipara as per ACOG recommendations. 
Stretching of perineum and vagina transmits the pain impulses to spinal cord 
through internal pudendal nerve (S2, S3, and S4) via fine myelinated, rapidly 
conducting ‘A ‘delta fibres. 
Pain intensity is increased by traction and pressure on bladder, rectum, parietal 
peritoneum, urethra, uterine ligaments, lumbosacral plexus, fascia and muscles 
of pelvic floor. 
THIRD STAGE: 
       Stage of expulsion of the placenta and membranes. It is usually takes 10-20 
min in both primi and multipara. 
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                 PHARMACOLOGICAL REVIEW 
PHARMACOLOGY OF BUPIVACAINE: 
        Bupivacaine was first synthesized by Ekenstam in 1957 and it was used 
clinically in 1963.It is a synthetic long acting amide group local anaesthetic. 
Structure: 
 
 It is a 2-piperidine carboxamide 1-Butyl N (2, 6, dimethyl, phenyl) mono 
hydrochloride, hydrate. Molecular weight: 288.pKa-8.125 
Pharmacokinetic properties: 
Absorption: 
 Related to site of injection (Intercostal>Epidural>Brachial 
plexus>subcutaneous). 
 Bupivacaine is a highly lipid soluble drug, so uptake into fat is rapid and 
it has a direct vasodilator effect. 
 A linear relationship between the total dose and the peak blood 
concentration achieved. 
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Distribution: 
 95% of drug binds to alpha-1-acid glycol protein in the plasma. 
 The Volume of Distribution is 4L/Kg and the foetal maternal transfer 
ratio is 0.2-0.4. 
Metabolism: 
 It gets metabolized in the liver by N-dealkylation and is conjugated 
           with glucuronic acid to 2, 6, pipecolyloxylidine. 
 N-desbutyl bupivacaine and 4 hydroxy bupivacaine are formed. 
 Hepatic disease potentiates its toxicity. 
Excretion: 
 5% of dose given is urine as pipecolyloxylidine. 
 16% of drug excreted unchanged. 
 The clearance is 0.47L/min. 
Presentation: 
 Available as 20 mL vial containing clear colourless solution of 0.25%, 
0.5% and 0.75% bupivacaine hydrochloride. 
 20 mL vial of 0.25% and 0.5% solution without preservatives are also 
available. 
 0.5% hyperbaric bupivacaine ampoules (4mL) with dextrose are 
available. 
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Mode of action: 
              Bupivacaine diffuses through neuronal sheath and axonal membrane in 
its uncharged base to the internal surface of cell membrane sodium ion channel 
where it combine with hydrogen ion to form cationic form which enters internal 
opening of sodium channel  and acts on receptor . Action is to block sodium 
channel and thus it decreases sodium ion conductance thereby preventing 
depolarisation of membrane. 
It blocks conduction and generation of nerve impulse by slowing propagation of 
nerve impulse, by increasing threshold of electrical excitation in the nerve and 
by reducing rate of rise of action potential. Therapeutic blood concentration 
doses achieved at 1-2 mcg/mL with no systemic side effects. 
Routes of administration and dose: 
It can be administered topically, intrathecally, epidurally or by infiltration. Dose 
is 2mg/kg. It can be used in varying concentration. 
• In spinal -hyperbaric 0.5% is used with duration of 75-150 min. 
• Epidural- it is used in concentration of 0.5%-0.0625% with onset of 10-
20 min and duration 180-300 min. 
• Infiltration -0.5-0.25% concentration being used with rapid onset of 
action and duration is 200 min. 
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• Peripheral nerve blocks-0.25-0.5% used. Onset of action is 10-20 min and 
duration is 400 min. 
• Obstetric analgesia-0.25 to 0.0625% concentration is being used. 
•  Predominant sensory blockade seen with concentration of 0.125% -
0.0625% and at concentration above 0.25 % motor blockade 
predominates. 
• It shouldn’t be used in Intravenous Regional Anaesthesia. 
• Average duration of action in epidural is 120-180 min and 5-6 hours for 
nerve blocks. 
Changes during pregnancy: 
Altered protein binding characteristics of bupivacaine in pregnancy lead to 
increased unbound fraction of drug that results in increased sensitivity to drug 
and rapid onset of block .Dose is 2mg/kg.25 
Safe limit is up to 150 mg in 4 hours. 
CVS: 
 Bupivacaine is markedly cardio toxic as it binds specifically to 
myocardial proteins. 
  It decreases peripheral vascular resistance and myocardial contractility, 
thus producing hypotension and cardiovascular collapse in toxic 
concentrations. 
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CNS: 
 Principle effect of this drug is reversible neural blockade which leads to 
characteristic biphasic effect in CNS. 
 Initially excitatory symptoms (light headedness, dizziness, auditory and 
visual hallucinations, tinnitus and fits) are due to blockade of inhibitory 
pathways. 
 Later CNS depression symptoms (drowsiness, disorientation and coma) 
are seen with increasing doses because of depression of both facilitatory 
and inhibitory pathways. 
 Limited passage across placenta to fetus since it is highly lipid soluble 
and protein bound. 
 Bupivacaine is undetectable in neonate plasma even 24 hours after 
caesarean section using bupivacaine induced spinal anaesthesia.26 
Toxicity / adverse effects: 
• Allergic reactions are extremely rare with amide group local anesthetics. 
• Toxic plasma levels- 2 to 4 mcg/mL .Dose required producing toxicity in 
fetus and newborn are much lesser that those adults. 
• Pregnant women are more sensitive to cardiovascular toxicity and 
bupivacaine induced cardiac toxicity are more resistant to CPR. Cardiac 
toxicity includes ventricular arrhythmia, Atrio ventricular blocks and 
cardiac arrest. Cardiac/CNS dose ratio is 3.7 ± 0.5. 
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Obstetric analgesia: 
         Amide local anaesthetic bupivacaine is being most commonly used for 
epidural labour analgesia because of its longer duration of action, higher degree 
of sensory block than motor blockade, less accumulation and less tachyphylaxis. 
           It is highly protein bound and lipid soluble, a special feature that limits 
placental transfer. The umbilical vein to maternal vein concentration ratio is 
approximately 0.3. 
           On epidural administration (without opioid), onset of action is within 8 to 
10 minutes, but it takes approximately 20 min for its peak action to occur. 
Duration is approximately 90 min. 
            Bupivacaine 6.25 to 12.5 mg (5 to 10 mL of 0.125% solution, 10 to 20 
mL of 0.0625% solution) combined with fentanyl or sufentanyl is adequate to 
initiate labour analgesia in most parturients.2 
PHARMACOLOGY OF FENTANYL 
Dr.paul Jannsen, a chemist who first synthesized Fentanyl in1960.It came into 
clinical practise in 1963.Fentanyl is a synthetic opioid, tertiary amine and 
phenylpiperidine derivative.28 
Structure: 
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Presentation: 
I. Available as clear, colourless Fentanyl citrate solution in ampoules 
containing 50µg/mL 
II. Available as transdermal patches which delivers 25/50/75/100mcg/hr 
over 72 hours. 
III. Lollipop –in six dosages (200/400/600/800/1200/1600 µg) that dissolves 
slowly in mouth. 
Potency: 
          It is 1000 times more potent than meperidine and 50 to 100 times more 
potent than morphine. 
          100 µg of fentanyl is equal to 75 mg meperidine and 10 mg morphine. 
Mode of action: 29, 30 
 Analgesic property is highly because of selective µ receptor agonist. 
 It acts by inhibition of calcium entry into the cell by inhibition of adenyl 
cyclase, calcium channels and decreases the release of excitatory neuro 
transmitter. It also facilitates potassium efflux and hyper polarization of 
cell membranes 
 Decreased membrane conductance thus decreases both pre and post 
synaptic responses. 
 Principle site of action through µ receptor at supraspinal sites. 
22 
 
 It also binds to kappa receptors causing sedation, supraspinal analgesia 
and anaesthesia. 
Intrathecal opioids: 
 Intrathecally opioids binds to G-protein coupled receptor (pre and post 
synaptic) present in Lamina I and II of dorsal horn of spinal cord. 
 Activation of receptor result in potassium channel opening (mu & delta) 
and calcium channel closure (kappa), with overall reduction in 
intracellular calcium. 
 Reduced release of excitatory neurotransmitter (substance P & glutamate) 
from presynaptic C fibres, but not ‘A’ fibres resulting in reduced 
nociceptive transmission. 
 
 The rapid transfer from the CSF to spinal cord, the epidural fat and the 
systemic circulation explains the rapid onset and the prompt decline in 
CSF levels of lipophilic opioid, accounting for the minimal rostral spread, 
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lack of delayed respiratory depression, and relatively small 
dermatomal band of analgesia. 
 It also enters into brainstem sites via posterior radicular artery. 
 Epidural fentanyl: 
 Epidural fentanyl bolus result in larger amount of drug available in 
epidural space than occurs at any time during infusion results in 
activation of dorsal horn opioid receptor in spinal cord. 
  Epidural Fentanyl act at spinal levels if administered as a bolus and at 
supra spinal levels if administered as infusions.  
 Epidural bolus cause segmental band of analgesia, the epidural fentanyl 
infusion produces non segmental analgesia. 
 Epidural fentanyl infusion produces analgesia by uptake into systemic 
circulation with redistribution to peripheral sites and brain. However, 
epidural bolus acts by specific spinal mechanisms. 
Pharmacokinetics and pharmacodynamics: 
 IV fentanyl has rapid onset of action and shorter duration than morphine. 
 Effect site equilibration time between brain and blood is 6.4 min. 
 Greater potency and rapid onset of action reflects greater lipid solubility 
of drug thereby facilitating transfer across blood brain barrier. 
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 75% initial dose of drug administered undergoes first pass pulmonary 
uptake. 
 Rapid redistribution to inactive tissues reflects shorter action of drug. 
 Effective analgesic concentrations are seen between 1 and 3ng/mL, while 
concentration between 1.5 to 3ng/mL, results in 50% reduction in 
ventilator response to CO2. 
Metabolism: 31 
It avidly binds to alpha acid glycoprotein and also bound to albumin. It gets 
metabolised by N-dealkylation in liver forming norfentanyl which undergoes 
hydroxylation to hydroxypropionyl derivatives. Cytochrome P_4503A4 plays 
an important and major role in fentanyl metabolism. 
Absorption and distribution: 
       It can get absorbed orally and its bioavailability is 33%.The Volume of 
Distribution is 0.88 – 4.4L/Kg. plasma protein binding is 81-94 %. 
Excretion: 
       10% of administered drug gets excreted in urine. Elimination half life is 
1.5-6 hours. Clearance is 0.4-1.5L/min. Patients with hepatic diseases have 
delayed clearance. 
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Analgesic potency: 31 
 It is 29 times more potent than morphine. Minimal analgesic dose is 
0.011mg/kg. 
 pKa of drug is 8.4 and therapeutic index is 323. 
  The onset and duration depends on the route of administration of drug. 
 IM –onset is 7-15 min peaks at 15 min and duration of action is 2 hour. 
 IV-onset 2-5 min and duration is 30-60 min. 
 Epidural route-onset is 4-6 min, peaks at 5-10 min and duration of action 
is 2-3 hours. 
Clinical effects: 
CVS: 
 At dose of 1µg/kg does produce significant effect on papillary muscle 
mechanics. 
 Doses of 7µg/kg during induction decreases heart rate but no change in 
mean arterial blood pressure. 
 10µg/kg produces 50% reduction in myocardial contractility. 
 20-25 µg/kg produces 15% reduction in heart rate, MAP, systemic and 
pulmonary vascular resistance and PCWP in patients with coronary artery 
disease. 
 It can cause histamine release. 
 Fentanyl causes bradycardia of vagal origin. 
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RS: 
• At 1mcg/kg- increase in tidal volume and decrease in respiratory rate 
• >3mcg/kg-decrease in tidal volume, respiratory rate and also reduction in 
ventilator response to hypoxia and hypercarbia. 
•  It has an antitussive property. 
• Chest wall rigidity (“Wooden – chest”.) due to its effect on mu receptors 
located on GABAnergic interneurons and it can be controlled by the early 
use of muscle relaxants. 
• Respiratory depression is of great concern with spinal and epidural 
opioid. 
CNS: 
It has CNS depressant action. Low doses (1-2mcg/kg) are devoid of 
sedative and hypnotic activity. Stimulation of Edinger Westphal nucleus 
results in miosis. Epidural fentanyl has less CNS effects than IV 
administration. 
 
GIT AND GENITOURINARY SYSTEM: 
        It can produce nausea, vomiting and decreased GI motility. It increases bile 
duct pressure by causing spasm of sphincter of Oddi. Retention of urine is due 
to increased tone of bladder detrusor, urethral and vesicle sphincter. 
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METABOLISM AND OTHERS: 
          At 50-100mcg/kg produces an increase in plasma cortisol, epinephrine, 
growth hormone, glucose and free fatty acids during surgery. 
Intrathecal opioid induced Pruritus: 
   Incidences are between 0-100%.pruritus is more common in pregnancy 
because altered opioid receptor population by hormones. Pruritus is commonly 
seen in face, neck and upper thorax. There is no relationship between intensity 
and dose of opioids. 
Mechanism of Pruritus and treatment of choice: 
• Mechanism has not been fully understood. 
• A new class of C fibres claims to be the cause and it is linked to central 
receptor networks. The nature of these networks is not clear, but there is a 
lot of µ & 5- HT3 receptors in and around trigeminal nucleus. 
• Ondansetron (5-HT3 antagonist) decreases pruritus after intrathecal 
morphine in pregnant females. 
• Anti histamines have no role in treatment since it is not caused by 
histamine release. 
• Propofol can be useful by inhibiting posterior horn transmission but 
sedative property avoids its use for the same. 
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• Opioid receptor antagonist nalaxone and naltrexone has been used 
successfully without reversing analgesic property. 
Synergism of local anesthetics and opioids: 32 
 Advantages of combining these two agents have been thought to be 
explained their different analgesic properties and their ability to block 
pain at two different sites. 
 Local anesthetics produce analgesia by blocking impulse transmission 
in nerve roots and dorsal ganglia whereas opioid act on opioid 
receptors in substantia gelatinosa. 
 When lipophilic opioid bolus is administered epidurally, it has 
biphasic response. Initial portion of drug rapidly absorbed into 
systemic circulation and act on supraspinal sites. Remaining portion of 
drug initially distributes in epidural fat and then slowly absorbed in 
blood stream over several hours. 
 It seems far more likely that the local anaesthetic provides a degree of 
spinal, segmental analgesia while simultaneously; the opioid is 
systemically absorbed and provides additional analgesia supraspinally. 
PHARMOCOLOGY OF ROPIVACAINE: 
 Ropivacaine is long acting amide local anaesthetic which is similar to 
bupivacaine in structure and pharmacodynamics. 
 Formulated as a single levorotatory enantiomer rather than a racemic 
mixture. 
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  Chemical name : S-(-)-1-propyl-2', 6'-pipecoloxylidide hydrochloride 
monohydrate 
STRUCTURAL FORMULA: 
 
Molecular formula: C17H26N2O•HCl•H2O         Molecular weight: 328.89. 
Mechanism of action: 33, 34 
          Ropivacaine reversibly blocks the entry of sodium into the nerve cell 
membranes, leading to decreased membrane permeability to sodium and raises 
the threshold for nerve excitability. Thus, it slows the nerve conduction and 
reduces the rate of rise of the action potential. 
Pharmacodynamics: 
          Ropivacaine has lesser cardiac and CNS adverse effects because of its 
stereo selective property. It has similar efficacy of bupivacaine and 
levobupivacaine in peripheral nerve blocking. It is less potent than bupivacaine 
when given neuraxially (intrathecal or epidural). It is associated with lower 
incidence of motor blockade when compared to bupivacaine35. It is currently a 
new agent of choice for regional anaesthesia. 
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Pharmacokinetics: 34 
 Plasma concentration varies with dose, injection site vascularity and route 
of administration. 
 It follows linear kinetics. C max is directly proportional to dose. 
 When given extradurally,   its absorption is biphasic (t1/2 is 4mins and 
4hrs) and complete. 
 Elimination depends upon the route of administration which is a rate 
limiting step. 
 Epidural ropivacaine has long half life than IV ropivacaine. Terminal half 
life of IV ropivacaine is 1.8 hours. 
 Highly bound to alpha 1 acid glycoprotein and 6% available in free form. 
 It easily crosses the placenta and degree of protein binding in fetus is less 
compared to mother. 
Metabolism: 
• Metabolised mainly by aromatic hydroxylation in liver. 
• The main metabolite is 3-hydroxyropivacaine excreted after conjugation. 
Other metabolites are 4-hydroxyropivacaine and 2’, 6’-pipecoloxylidide 
(PPX).  
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• When given IV, 86% excreted via urine out of which only 1% is 
unchanged fragment. 
• The 2’, 6’-pipecoloxylidide has longer t1/2 and lower clearance after 
infusion through epidural. 
• Clearance – unbound ropivacaine – 13.94L/h/Kg & Clearance – Total 
ropivacaine – 0.555L/h/Kg. 
• Volume of distribution – 65.57L/min 
• Terminal t1/2 of ropivacaine - 3.3hrs & Terminal t1/2 of PPX – 17.8 hrs. 
Indications: 
 Spinal anaesthesia  
 Epidural anaesthesia and analgesia 
 Peripheral nerve blocks 
 Local infiltration 
Contraindication: 
 Hypersensitivity 
 Premature children 
 Paracervical block in obstetrics 
 Intravenous regional anaesthesia 
 Hypovolemia 
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Dosage and administration: 
 Spinal – 2-3mL of 0.75 %( 7.5mg/mL) with doses between 15-22.5mg 
results in sensory block up to T4 or T5. 
 Epidural block with 6-14 mL of 0.2% ropivacaine provide adequate 
analgesia 
 Caudal – 1mg/kg, 0.2% or 2mg/mL produces a level below T12. 
Adverse effects: 
 Hypersensitivity  reactions 
  Main effects - Hypotension ,bradycardia, nausea, vomiting, , 
 Fever, paresthesia, headache, pruritus, urinary retention, rigors and back 
pain. 
Less common side effects: CNS toxicity, cardiac toxicity 
COMBINED SPINAL EPIDURAL TECHNIQUE: 
        The Obstetric Anaesthetists Association, UK guidelines in 200536 suggest 
the use of CSEA technique in specific situation like 
 Advanced stages of labour where the rapid analgesia is desirable. 
 Very early stages of labour where local anesthetics are avoided. 
 In difficult epidural as CSEA decreases epidural failure rate. 
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The CSEA technique has been accepted as an ideal technique because it 
combines rapid profound analgesia of spinal with flexibility and longer duration 
of epidural techniques. It also reduces or eliminates the disadvantages of both 
spinal and epidural anaesthesia, while preserving their advantages37. 
Advantages of combined spinal epidural: 
Spinal anaesthesia has its own advantages38 are 
 Rapid onset of action. 
 Definite end point for placement of needle. 
 More reliable and producing excellent analgesia. 
 Prevents systemic toxicity by reducing dose requirements. 
Disadvantages of spinal 38are: 
 Risk of post dural puncture headache (PDPH). 
 Lack of top up methods to prolong or optimize blocks. 
Advantages of epidural anaesthesia38 are: 
 Familiar technique  
 Widespread use 
 Absence of PDPH unless accidental dural tap. 
 Slower and predictable onset of hypotension compared to spinal 
anaesthesia 
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 Indwelling catheters allows top ups, modification and extension of 
blocks. 
Disadvantages of epidural anaesthesia38 are: 
 Slow to establish the block. 
 May be patchy block or asymmetrical. 
 Some nerve roots are difficult to block. 
 Comparatively large volume of local anaesthetic required. 
Thus CSEA technique offers several advantages38: 
 Better quality of analgesia. 
 Rapid onset. 
 Low total dose of local anaesthetics. 
 Presence of epidural catheter allows us to add local anesthetics and other 
drugs to optimise and prolong the spinal block. 
Characteristics of combined spinal epidural: 
It is a multi compartmental block that involves intentional dural puncture 
followed by epidural drug administration. This introduces the possibility of drug 
transfer from epidural to subarachnoid space which alters characteristics of 
block39. 
Pressure in subarachnoid space is greater than epidural space by 5-15cm 
H20.This pressure gradient prevents drug flux into subarachnoid space. 
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Epidural administration of drugs transiently abolishes this gradient and allows 
the drugs to enter into subarachnoid space39. 
Drug transfer depends on needle type, size of hole and property of drugs. 
Epidurally administered drugs enter the subarachnoid space following dural 
puncture by spinal needle, accidental dural puncture by epidural needle or by 
migration and displacement of catheter .Therefore, infusions of low 
concentration local anesthetics are always safer than high concentration 
boluses39. 
Techniques of needle insertion and variation: 
Numerous CSE techniques40 are available. 
 Subarachnoid block followed by epidural catheter insertion at same or 
higher interspace. 
 Epidural catheter insertion followed by spinal needle placement at lower 
interspace. 
 A spinal needle besides epidural needle in same interspace by specially 
designed needle. 
 Needle through needle technique in which epidural space identified and 
dural puncture is made with long fine bore needle inserted through 
epidural needle. Free flow of CSF indicates correct placement of needle. 
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Opioid alone or local anesthetics and opioid injected intrathecally. 
Epidural catheter inserted 3-5 cm after withdrawing spinal needle. 
Needle through needle versus separate needle technique: 
• Holmstrom et al 39in 1993 found that 64% of departments in Sweden 
preferred separate needle technique. 
• In a random study of 100 parturients, Lyson et al40 compared needle 
through needle technique and separate needle techniques. He found that 
separate needle has lower spinal failure rate (4% vs. 16%), less 
hypotension and less time for insertion than needle through technique. 
• Casati et al 41found that higher rate of hypotension (23%) and spinal 
failure rate (5%) in needle through needle group than separate needle 
group (13% and 1.6% respectively). 
• Cost of special equipments for needle through needle is higher than 
epidural needle and 27G point spinal needle. 
Combined spinal epidural versus traditional epidural: 
 Cochrane review and CSE15: 
In CSE, three types of interventions were available. 
-opioid alone. 
-local anaesthetics plus opioids. 
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-Null CSE –no intrathecal injections after dural puncture. 
By using these definitions, comparison falls into six types. 
• 1. LA plus opioid CSE versus traditional epidural 
• 2. LA plus opioid CSE versus low-dose epidural 
• 3. opioid only CSE versus traditional epidural 
• 4. opioid only CSE versus low-dose epidural 
• 5. opioid only CSE versus test LA/opioid epidural 
• 6. null CSE versus traditional epidural 
 When CSE compared with traditional epidural, mean time of onset of 
analgesia is three minutes shorter in CSE groups (MD -2.87, 95% CI -
5.07 to -0.67, two studies and 129 women). Lesser urinary retention (RR 
0.86, 95% CI 0.79 to 0.95, one study,704 women) and fewer assisted 
vaginal births(RR 0.80, 95% CI 0.67 to 0.97, six studies, 1015 women) in 
the CSE group15. 
 Comparison of CSE with low dose epidural, mean onset of analgesia is 
five min shorter in CSE group  (average MD -5.42, 95% CI -7.26 to 3.59, 
five studies, 461women) and effective pain relief at ten min after first 
injection  (RR 1.94, 95% CI 1.49 to 2.54, one study, 101 women)15. 
 Pruritus is more common in CSE group (RR 1.94, 95% CI 1.49 to 2.54, 
one study, 101 women) than low dose epidural15. 
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Camman et al42 conducted a study on 1,532 healthy parturient who received 
either CSE or conventional epidural during six months period in KK womens 
and children hospital, Singapore. 
• CSE needs lesser analgesic requirements(p<0.01) 
• CSE commonly preferred in 80% of all neuraxial techniques (vs. 20% 
EA) 
• CSE commonly used in multiparous parturients (OR 2.03, p <0.01), in a 
more painful (OR=1.61, p=0.03) and advanced stage of labour (OR=1.12, 
p=0.03)42 
• CSE has higher patient satisfaction score  (OR=1.77, p <0.026)  
•  Increased risk of Pruritus (29% vs. 14%, p <0.01) but lower risk of post 
block neural deficits (0% vs. 2%, p <0.01) seen in CSE than EA42. 
• Thus CSE is a safe and good alternative to EA for labour analgesia. 
Miro et al 43investigated a study conducted in 6497 women who received 
regional anaesthesia in 2005. 
  4533 received epidural analgesia (69.8%) and 1964 received combined 
spinal-epidural (30.2%) for labour43. 
 Pruritus, back pain and paresthesia were seen more in CSE group than 
EA. 
 Quality of analgesia was better in CSE. 
 No difference regarding accident dural puncture and PDPH were seen. 
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 Labour outcome and safety was similar in both groups43. 
American Society of Anaesthesiologist guidelines on obstetric anaesthesia 
200744(comparing CSE with EA, literature supports) 
 Equivalent and faster onset of analgesia with CSE  
 Increased rate of Pruritus is more with CSE  
 Equivocal about nausea, hypotension, mode of delivery, motor block, 
maternal satisfaction with analgesia, fetal heart rate changes and APGAR 
scores43. 
Opinions between ASA members and the consultants when comparing CSE 
with EA are 
• Both agree fast onset of analgesia with  CSE 
• Both disagree that CSE increases neonatal or fetal adverse effects43 
• Equivocal regarding overall analgesic efficacy, motor block and duration 
of labour. 
• Consultants were disagreeing but ASA members are equivocal about CSE 
increases maternal side effects43. 
Rapid dilatation and shorter duration of labour with CSE: 
 Michael. P Nageotte et al studied 775 primiparous women who 
requested labour analgesia and results were lesser rate of instrumental 
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deliveries and increased rate of spontaneous deliveries in CSE group than 
conventional EA group. No difference in incidence of dystocia and rate of 
operative deliveries among groups45. 
  Lawerence C Tsen et al conducted random study among healthy 
nulliparous women and concluded that increased rate of cervical 
dilatation in CSE groups than EA groups46. 
 Amit.G.Bhagwat et al investigated 60 nulliparous parturient who 
participated in study and results were CSE technique associated with 
rapid cervical dilatation and shorter duration of labour47. 
 Abouleish et al study also supported CSE groups had rapid onset of 
analgesia in advanced stages of labour in term parturients48. 
Fetal heart rate changes: 
 In a study conducted by Palmer et al, found out that lower incidence of 
fetal heart rate changes and no difference in neonatal outcome, while 
comparing both CSE and conventional EA groups49. 
 Increased incidence of fetal bradycardia and non reassuring FHR changes 
immediately after CSE .It has been suggested that sudden onset of 
analgesia decreases maternal circulating catecholamines which may be 
the cause for fetal bradycardia. These changes are usually transient and 
resolves in 5-8 minutes50. 
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 Transient non reassuring FHR changes may be due to uterine hyper 
stimulation which is due to sudden decrease in maternal catecholamines 
and hypotension following sympathetic blockade51. 
 Gorman et al study shown that fetal bradycardia may occur in absence of 
hypotension or uterine hyper stimulation and it is unrelated uteroplacental 
insufficiency52. 
Quality of analgesia: 
           Miro et al, a retrospective study reveals that CSE and EA groups were 
compared in terms of safety and effect on type of delivery, better quality of 
analgesia seen with CSE group45. 
Neuraxial analgesia and outcome: 
• Many studies revealed that rate of incidence of emergency caesarean 
section are lower in CSE group than conventional epidural53, 54. 
• In C. R. Cambic and C. A. Wong  et al study 55,it has been shown that 
effective early initiation of neuraxial labour analgesia doesn’t increases 
risk of caesarean delivery. Effective analgesia doesn’t affect first stage 
but it increases duration of second stage. There has been increased rate of 
instrumental vaginal delivery with neuraxial technique which may be due 
to many confounding factors (obstetric factor, technique, local anaesthetic 
drug concentration, maintenance and degree of analgesia) 55. 
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Accidental Dural puncture and Continuous spinal analgesia: 
   In a study conducted by S.V Rutter, F Shields, C.R Broadbent, M 
Popat, R Russell56 , labour epidural were placed in 15030 patients and 72 
accidental dural punctures (ADP) were identified. Group I-34 patients converted 
into continuous spinal analgesia with intraspinal catheter and Group II- 37 
patient’s epidural was resited in another space. Both groups were compared in 
terms of maternal safety, quality of analgesia and mode of delivery. 
  After epidural resiting, three ADPs noted .High level of blocks were 
noted & managed with intubation and ventilation. PDPH was seen in 71% vs. 
81 %( group I vs II) (p=0.45).Epidural blood patch was done in 50% vs. 73 %( 
group I vs II) (p=0.008).Hence following ADP, continuous spinal analgesia is a 
simple and effective method than resiting an epidural57. 
• In Riger et al study, cauda equina syndrome is noted with use of smaller 
gauge micro catheter (24 G or smaller). It was postulated that smaller 
diameter of catheter results in laminar flow predisposing nerve roots to 
higher concentration of local anesthetics58. 
• Ayad et al observed that after ADP, of 20G catheter inserted into 
intrathecal space and it was left in place for 24 hours after delivery, lower 
incidence of PDPH (6.2%) rather than removing catheter immediately 
(51.4 %) 59.  
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COMPLICATIONS AND ITS MANAGEMENT: 
Hypotension18: 
It is often defined as 20%-30% drop in systolic blood pressure from 
baseline. Hypotension following intrathecal opioid is due to pain relief rather 
than sympathectomy. Uncorrected prolonged hypotension leads to decreased 
uteroplacental blood flow results in fetal hypoxia and acidosis. Management 
includes left lateral position, 100% oxygen administration, rushing IV fluids, if 
still hypotensive, ephedrine 6 mg has to be given every two minutes until blood 
pressure is corrected to restore uterine artery perfusion promptly. 
Inadequate Neuraxial Analgesia18: 
 First the other causes of pain (distended bladder, rupture uterus) have to 
be ruled out. 
 Then the location of the catheter has to be confirmed. 
 If in doubt, the catheter has to be replaced. 
 If  the catheter is placed correctly  but the extent of the block is 
inadequate(i.e. T10-S4 required for late labour) 
•  Dilute solution of local anesthetics has to be injected as per group 
(5-15mL). 
• Alternative maintenance technique (decreasing concentration, 
increasing volume) have to be chosen. 
• Placing the less blocked side in dependent position 
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• If all above manoeuvres doesn’t help, the catheter can be replaced. 
 If catheter is in space ,but the patient has breakthrough pain despite the 
adequate extent of  blockade ,then 
  A more concentrated solution of local anesthetics with or without 
an opioid can be injected. 
• Alternative maintenance technique (increasing concentration of 
local anesthetics) can be chosen. 
Intra Vascular Placement of Catheter and Local Anaesthetic Systemic 
Toxicity20: 
 Confirmation of intravascular placement of catheter can be done with 
negative aspiration of blood in presence of multiorifice catheter. 
 If blood is seen during aspiration, then it can be flushed with saline and 
the catheter has to be withdrawn 1 cm and the aspiration test can be 
repeated. One can proceed further if aspiration test is negative. 
 If not then the catheter has to be removed and can flush with saline and 
can be tried in another space. 
With the usage of less concentration of local anesthetics, chances for LA 
toxicity is very less. This plays a major role when operative delivery is planned. 
If toxicity occurs, then the position of the catheter has to be confirmed with a 
traditional test dose (3 mL of 1.5% lignocaine with adrenaline 5µg/mL). 
 Intravascular injection of large doses of local anesthetics causes 
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• CNS symptoms (perioral numbness, tinnitus, dizziness, restlessness, 
seizures, loss of consciousness). 
• CVS effects ranging from increased blood pressure to bradycardia, 
ventricular fibrillation and tachycardia. 
• Bupivacaine induced cardio toxicity may be fatal in pregnant women. 
Management includes treatment of convulsion with benzodiazepines or 
barbiturates, supporting ventilation and oxygenation, if needed advance cardiac 
life support may be initiated. Amiodarone may be indicated in life threatening 
ventricular arrhythmias. Early delivery of infant should be considered after 4 
minutes of failed CPR, because it may improves likelihood of resuscitation. If 
available, an intravenous bolus administration of 20% lipid emulsion can be 
considered. 
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 Accidental Dural puncture18, 20: 
During catheter placement if dural puncture is encountered, then one can 
try in another space. If second attempt also fails, then it can be converted into 
continuous spinal labour analgesia.  
 
 
High (or) total spinal blockade20: 
Unexpected high level or total spinal blockade can result from 
 Unintentional placement of catheter in subarachnoid or subdural space 
and injection of epidural dose of local anaesthetic through the catheter. 
 Overdose of the drug in epidural space. 
 Migration of catheter into subarachnoid or subdural space during the 
course of labour. 
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Risk is more when operative delivery is planned .Communication with 
the patient is necessary in assessing the onset of total or high spinal blockade. 
Symptoms like agitation, difficulty in speaking, dyspnea, and profound 
hypotension may occur. Patient may lose his consciousness and stop breathing 
because of hypo perfusion of the brain and brainstem. 
During this management includes 
• Maintaining patient in left lateral position to avoid aortocaval 
compression. 
• Administration of hundred percentage oxygen 
• Positive pressure ventilation through endotracheal tube. 
• Monitor maternal vitals, fetal heart sound and ECG. 
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• Support maternal circulation with intravenous fluids and 
vasopressors if needed. 
• Epinephrine can be administered if needed. 
• Administration of small dose of sedative-hypnotic agents. 
 
Intrathecal Opioid Induced Pruritus18: 
• Incidence of pruritus is 0-100% following intrathecal opioid. 
• Anti –histamines have no role, because this is not related with histamine 
release. 
• Use of opioid antagonist relieves pruritus but it reverses analgesia. 
• Highest concentration of serotonin (5-HT3) receptors is located on dorsal 
horn of spinal cord and trigeminal nucleus of medulla. Activation of 
these receptors plays a role in pruritus. Hence 5-HT3 antagonist 
(Ondansetron 4 mg) may be used to relieve the pruritus. 
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ANAESTHESIA   FOR EMERGENCY CAESERIAN SECTION: 
Emergency LSCS requires sensory blockade level up to T4 which typically 
requires a volume of 15- 20 mL of local anaesthetics with one or more 
adjuvants. 
Extension of epidural anaesthesia in labour room can be initiated with 5-10 
mL of 2% lignocaine (with adrenaline 2µg/mL) while shifting the patient to OT 
in left lateral position. 
 Sensory blockade level is assessed once patient reaches the OT. If 
blockade is bilateral and moving cephalad, additional 5- 10 mL can be 
given in increments to achieve level T4. 
 Addition of 50-100µg fentanyl provides good quality of analgesia. 
 Fractionated dosing schedule offers advantages like greater hemodynamic 
stability, minimal compression of dural sac which allows safer conversion 
to spinal anaesthesia if epidural anaesthesia is not successful and early 
sensory blockade which allows  surgeons to initiate surgery  very well 
early prior to full establishment of level T4.M 
Maternal Cardiac Arrest18: 
Following Cardiac arrest one can resuscitate as per 2010 American Heart 
Association guidelines.  
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Intrauterine Foetal Resuscitation18: 
Impairment of oxygen delivery to the fetus results in significant fetal 
hypoxia and acidosis. During fetal distress, the following resuscitative measures 
have to be done. 
 Left lateral position 
 High flow oxygen administration 
 Rushing intravenous fluids 
 Tocolysis to reduce uterine contractions. 
 Vasopressors for treating maternal hypotension. 
 Amnioinfusion for improving uterine blood flow. 
After delivery the newborn has to be assessed and resuscitated as per 
2010 AHA Newborn Resuscitation Guidelines. 
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Intrathecal fentanyl: 
 In a popular study, 84 parturients in active labour divided into seven 
groups to find effective doses of intrathecal fentanyl. Fentanyl doses of 
5,10,15,20,25,35,45 mcg were allocated in each group as a part of CSE 
technique. They concluded that rapid profound analgesia with intrathecal 
fentanyl with minimal side effects. If dose of fentanyl increased beyond 
25 mcg, there was little benefit60. 
 In current practice, use of low doses of bupivacaine with fentanyl 
intrathecally has become very popular. Addition of fentanyl to 
bupivacaine reduces bupivacaine doses by 50%.Lower concentration of 
bupivacaine produces very minimal motor block and without fentanyl it 
doesn’t produce effective analgesia. The dilute concentration produces 
effective analgesia without affecting cardiovascular stability61. 
EPIDURAL ROPIVACAINE AND BUPIVACAINE WITH FENTANYL: 
Stienstra et al (1995)62 conducted a prospective randomized study in 76 
term parturients; they compare the effects of initial 10 mL of 0.25% 
bupivacaine with 0.25% ropivacaine and continuous infusion of same drug at 6-
12 mL/hr. Top up of 6-10 mL given as and when required. No statistical 
difference was found between two groups with regards to onset of analgesia, 
contraction pain, intensity and duration of motor block.  
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Eddleson JM et al (1996)63 compared 0.2% bupivacaine with 0.125% 
ropivacaine in 104 parturients for labour epidural analgesia. Onset of pain relief, 
maternal satisfaction, and level of sensory blockade were similar in both the 
groups. The incidence, duration and degree of motor block were slightly but not 
significantly less in the ropivacaine group. Higher incidence of spontaneous 
vaginal delivery was seen in ropivacaine group. No significant difference in 
neonatal outcome. 
Owen et al (1998) 64compared 0.125% bupivacaine with 0.125% 
ropivacaine using patient controlled epidural analgesia (PCEA). They found 
both groups were clinically similar. No difference was noted with regards to 
sensory levels, verbal pain, duration of labour, mode of delivery and patient 
satisfaction. 
Yaakov Beilin et al(1999)65  parturients received 0.2% ropivacaine 
(group I),0.15% ropivacaine( group II),0.1% ropivacaine (group III) with 13 mL 
bolus and additional 5 mL given after 5 min if analgesia was not adequate,  
study was concluded after the degree of pain relief noted after 15 min . They 
found adequate analgesia noted 93 % in group I, 64% in group II and 33% in 
group III. 0.2 % ropivacaine provides significant analgesia and hence concluded 
that ropivacaine concentration for initiation of labour analgesia should be 
minimum 0.2%. 
Meister et al (2000)66 randomised 150 parturients to receive either 
0.125% ropivacaine with fentanyl 2µg/mL or 0.125% bupivacaine with fentanyl 
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2µg/mL by using patient controlled epidural analgesia. No differences in pain 
score, local anesthetics used and patient satisfaction were noted between the 
groups. Ropivacaine group had significantly lesser motor block than 
Bupivacaine group.  
Campell et al(2000)67conducted a study in 40 nulliparous women in 
early active labour received either 20 mL of 0.08%bupivacaine with fentanyl 
2µg/mL or 20 mL of 0.08% ropivacaine with fentanyl 2µg/mL to initiate labour 
epidural analgesia. They found that ropivacaine group had effective analgesia 
without causing clinically significant adverse maternal side effects while 
preserving maternal ability to void urine and ambulate. 
Fettes et al (2000)68 conducted a double blinded randomised study in 40 
labouring nulliparous women to compare continuous infusion or intermittent 
bolus of Ropivacaine with fentanyl for epidural analgesia. They found no 
significant differences in patient characteristics, sensory/motor block and 
maternal/neonatal outcome between two groups. However, the total dose of 
drug used was lower and time to first rescue bolus was longer in intermittent 
bolus group. Hence they concluded that intermittent bolus is a more efficacious 
mode. 
Fischer et al (2000)69 compared the administration of 0.1% ropivacaine 
and 0.1% bupivacaine with sufentanyl 0.5µg/mL via PCEA .5 mL of above 
administered as test dose followed by a loading dose 5 min later. PCEA regimen 
used was 5 mL bolus and 10 min lockout period. Two groups did not differ in 
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VAS score, volume of drug used, mode of delivery or anaesthetic used. 
Ropivacaine group needed frequent top ups during second stage and associated 
with prolonged second stage. Maternal satisfaction was better with bupivacaine. 
Ropivacaine group had significantly lesser motor blockade during first stage of 
labour. They concluded ropivacaine produce less motor block but are clinically 
less potent. 
Helene Fine gold et al(2000)70 did a randomised double blinded study 
with group I received 10 mL bolus of 0.25 % bupivacaine and infusion of 
0.125% bupivacaine with fentanyl 2 µg/mL and group II received 10 mL bolus 
of 0.2 % ropivacaine and infusion of 0.1% ropivacaine with fentanyl 2µg/mL . 
No difference in median VAS score was observed between two groups. 
However, 80% of ropivacaine group had no demonstrable motor block after first 
hour compared with 55% of patient in bupivacaine group. They concluded that 
both produced satisfactory analgesia but ropivacaine infusion had lesser motor 
block. 
Dresner M et al (2000)71 study compared ropivacaine 0.2% ropivacaine 
with bupivacaine0.1% with fentanyl for labour analgesia. Both groups received 
15 mL of loading dose, infusion rate of 8 mL/hr and breakthrough top ups was 
given with 10 mL 0.25% bupivacaine. Ropivacaine group needs lesser routine 
topups and fewer escape topups. No significant difference in motor blockade 
and mode of delivery between two groups. 
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     Fernández-Guisasola J et al (2001)72 compared equipotent doses of 
0.0625% bupivacaine with fentanyl and 0.1% ropivacaine with fentanyl as 
continuous infusion. Both groups receive initial bolus of 8 mL of 0.7% 
lignocaine with 50µg fentanyl and continuous infusion of 0.0625% bupivacaine 
with fentanyl2µg/mL or 0.1%ropivacaine with fentanyl 2µg/mL depending 
upon group. Top up boluses of 5 mL given for breakthrough pain. No 
significant difference was noted with regards to pain intensity, VAS score, and 
mode of delivery, maternal and fetal outcomes. They concluded that both are 
equally effective but ropivacaine was less potent than bupivacaine. 
H.J.Clement et al (2002)73study compared 0.1% ropivacaine with 
sufentanyl0.5µg/mL versus 0.10%bupivacaine with sufentanyl 0.5µg/mL. No 
significant difference observed. They concluded both are equally effective. 
Lacassie HJ et al (2002)74 conducted a study to determine MLAC 
(minimum local anaesthetic concentration) motor block for bupivacaine and 
ropivacaine. They found motor block MLAC for bupivacaine was 0.326% and 
for ropivacaine0.497%.The ropivacaine/bupivacaine potency ratio was 0.66 and 
had similar potency for those two drugs. 
Owen MD et al (2000)64 conducted study to find out concentration of 
ED50 doses of ropivacaine and bupivacaine in labour epidural.59 parturients 
were randomised to receive 0.075% bupivacaine or ropivacaine with fentanyl 
using PCEA. Analgesia was initiated with 20 mL of study solution with PCEA 
settings: 6 mL/h basal rate, 5 mL bolus, 10 min lockout, and 30 mL/h limit. 
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Breakthrough pain was treated with 10-mL boluses of study solution. They 
concluded that both are equally effective and no difference with respect to pain 
score, satisfaction, motor/sensory block, labour outcome and adverse effects. 
Lee BB et al(2002)75compared ropivacaine 0.1% with 0.2% and to look 
for effects on addition of fentanyl.58 parturients received 0.2% ropivacaine 
initially and then they randomised to receive infusion of either of following  at 
10 mL/hr: Ropivacaine 0.1%(R1),Ropivacaine 0.2%(R2), Ropivacaine 0.1% 
with fentanyl 2µg/mL(RF).Additional analgesia were given with 5 mL bolus of 
0.2% ropivacaine .All groups required equal supplementary top ups and provide 
equal analgesia.VAS score in R2 and RF was equal and lower than 
R1.Hypotension was more in RF when compared to R1 and R2. Patient 
satisfaction, neonatal and maternal outcomes were similar among all groups. 
They concluded that 0.1% ropivacaine alone provided adequate analgesia 
during first stage of labour. Addition of fentanyl to ropivacaine 0.2% improved 
quality of analgesia equal to ropivacaine 0.2% alone. 
Fernandez C et al (2003)76 compared 0.1% ropivacaine(R group) with 
0.125% bupivacaine (B group) for motor block and analgesic efficacy in 
continuous epidural infusion. Analgesia, hemodynamics and fetal characteristics 
were similar .R group required frequent top ups but was not statistically 
significant. Motor block was more in group B. Both drugs were equally 
effective and ropivacaine offered no advantage over bupivacaine. 
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Boselli et al (2003)77 compared 0.15% ropivacaine and 0.1% ropivacaine 
both with 0.5µg/mL sufentanyl using PCEA for labour analgesia. They found 
that 0.1% group was equally as effective as 0.15% group with 30% dose sparing 
effect and 40% cost reduction. 
Atienzar MC et al (2004)78 conducted a randomised study to found out 
efficacy of 0.1% ropivacaine with 2µg/mL fentanyl in labour analgesia in 80 
parturients. Both groups received initially 0.2% ropivacaine and then 
randomised to receive either 0.1% ropivacaine with fentanyl 2µg/mL at 10 
mL/hr (group 1) or 0.2% ropivacaine with fentanyl 2µg/mL at 8 mL/hr (group2) 
as epidural infusions. Additional topups were given with 0.2% ropivacaine. No 
difference in VAS score, maternal and fetal outcome, patient satisfaction score 
and mode of delivery between two groups. Amount of drug used in group 1 was 
lower and were equally effective as group 2. 
Neera Sah et al. (2007) 79conducted a prospective randomised study to 
compare efficacy of bupivacaine 0.125 %( group1), levobupivacaine0.125 %( 
group2) and ropivacaine0.1 %( group 3) in 162 labouring ASA I &II 
parturients. All patients in three groups received a bolus of 8 mL of concerned 
local anaesthetics with fentanyl 100 µg followed by infusion of 12 mL/hr of 
local anesthetics with fentanyl2µg/mL. No significant difference in pain (VAS 
score), motor and sensory block among three groups. 
NganKee WD et al (2010)80 compared the dose response curves of 
bupivacaine and ropivacaine for labour analgesia. 300 nulliparous patients were 
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randomLy given epidural ropivacaine (7, 15, 20, 30, 45, or 60 mg) or 
bupivacaine (5, 10, 15, 20, 30, or 40 mg) in 20 mL of saline.VAS score 
recorded for 30 min. data were analysed using non linear regression.ED50 was 
greater for ropivacaine than bupivacaine but ED90 was similar. Potency ratio at 
ED50 for ropivacaine: bupivacaine was 0.75.Hence they concluded ropivacaine 
was less potent than bupivacaine with similar dose –response characteristics. 
 
           
                 LABOUR ANALGESIA METHODOLOGY 
This comparative clinical study of combined spinal epidural labour 
analgesia for vaginal delivery with intrathecal fentanyl 25 μg +epidural 0.125% 
bupivacaine 10 mL with 2μg of fentanyl/mL versus intra thecal fentanyl 25μg+ 
epidural 0.1% ropivacaine 10 mL with 2μg of fentanyl/mL was conducted in 60 
parturients, who wished and opted for painless labour in Kilpauk Medical 
College and Hospital, Chennai after obtaining permission from the Institutional 
Ethical committee. After taking a written informed consent, only those who 
fulfilled the selection criteria were included in this study. 
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Inclusion criteria: 
1) Pregnant women with singleton pregnancy, term gestation, cephalic 
presentation, in active first stage of labour, the mothers who are booked 
and all antenatal investigations are within normal limits. 
2) Cervical dilation >3 cm and <5 cm. 
3) Age 18-35 years, Height >150 cm. 
4) BMI 18-25 
5) Primi gravida. 
 
Exclusion criteria: 
1) Mothers with co-existing diseases like diabetes, hypertension, PIH, 
bronchial asthma, epilepsy, thyroid disorders, IHD, valvular heart 
disease, previous LSCS 
2) Spine abnormalities and local skin infections. 
3) Coagulopathies. 
4) Cephalo pelvic disproportion. 
5) Preterm gestation. 
6) Fetal distress. 
 
 Antenatal mothers in antenatal wards and those who attended outpatient 
department were counselled about labour analgesia. Thorough assessment 
of mothers including investigation, systemic examination was done. 
Those mothers who fulfilled inclusion criteria when enters the active 
stage of labour was enrolled in our study. 
 The study population consisted of 60 parturients allocated into two 
groups, 30 in each group. The parturients satisfying the selection criteria 
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were randomized by computer generated randomization table into two 
groups of thirty each –Group B and Group R. The randomization 
sequence was prepared in double-blinded manner. The study blinding was 
broken after the statistical analysis. 
 (1)Group B (Bupivacaine): received intrathecal fentanyl 25μg+epidural 
0.125% Bupivacaine 10 mL with 2μg of fentanyl/mL. 
 
 (2)Group R (Ropivacaine): received intrathecal fentanyl 25 μg +epidural 
0.1% Ropivacaine 10 mL with 2μg of fentanyl/mL. 
 
PREPARATION OF THE PARTURIENT: 
 She was prepared as per the routine preparation done for delivery, in 
addition to preparation of back to perform epidural block. 
 The onset of active labour, degree of cervical dilatation and the adequacy 
of pelvis for vaginal delivery were assessed by attending obstetrician, 
before performing the block. 
 Monitors (NIBP, pulse oximeter, ECG and CTG) connected and base line 
vitals were recorded. 
 An IV line was started on the non dominant hand with an 18 G cannula. 
 The parturient was preloaded with 500- 1000 mL 0f Ringer lactate 
solution. 
 Anti aspiration prophylaxis (Inj. Ranitidine50mg and Ondansetron 4mg 
IV) was given. 
 All equipments needed for airway management and resuscitation of the 
mother and baby was kept ready before performing the block. 
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The autoclaved epidural tray used for performing the block contained the 
following 
1. Disposable epidural set-18 G Tuohy needle with catheter 
2. Disposable 25 G Spinal needle. 
3. Disposable syringes 2mL, 5mL and 10mL. 
4. Glass syringes 5 mL with a freely moving plunger. 
5. Skin towel 
6. Sterile dressings 
7. Sterile swabs 
8. Sponge holding forceps 
9. Drugs- Bupivacaine hydrochloride 0.5% vial 
                 Ropivacaine 0.2% ampoule 
                 Fentanyl 50μg/mL ampoule 
                 Lignocaine hydrochloride 2% vial 
Normal Saline for dilution. 
Preparation of epidural bupivacaine and ropivacaine: 
The epidural drug preparation (including top up doses) was done by the duty 
assistant professor who prepared it according to the group allocation. 
 2 mL of 100mcg fentanyl (50 µg/mL) diluted with 3 mL of normal saline 
which gives 20mcg /mL fentanyl. 
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 For group B-2.5mL of 0.5 % bupivacaine mixed with 20 mcg of prepared 
inj. fentanyl (1mL) and 6.5 mL of normal saline which gives 0.125% 
bupivacaine with fentanyl 2 mcg/mL. 
  For group R- 5mL of 0.2% ropivacaine mixed with 20 mcg of prepared 
inj. fentanyl (1mL) and 4mL of normal saline which gives 0.1% 
ropivacaine with fentanyl 2 mcg/mL. 
 
Performing the Block: 
Block was performed after shifting patient to operation theatre. We used 
separate needle CSE technique for this study. We initiated subarachnoid 
blockade followed by epidural catheter insertion at a higher space. 
1.  In sitting/right lateral position with monitors attached. 
2. under strict aseptic precautions. 
3.  Ideal space chosen for CSE was L3-L4/L4-L5 
4.  Local infiltration with 1 cc of 2% Lignocaine was given in the L3-L4/L4-
L5 for both the spinal epidural needle placements. 
5. Intrathecal fentanyl 25 μg was given with 25 G spinal needle in the L4-
L5 space. 
6. With bevel directed upwards, a midline approach with Tuohy needle was 
done and epidural space was identified by loss of resistance technique. 
Epidural placement was done in absence of uterine contraction at one 
space above the spinal injection. 
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7.  Catheter was placed 3-5 cm in the epidural space. 
8. After negative aspiration for blood and CSF, the epidural catheter was 
secured. Two mL of prepared solution was given as epidural test dose. 
9. Each increment of the therapeutic dose was considered the test dose. 
These  precautions were followed in all bolus injections of local 
anaesthetic through an epidural catheter. 
10. With patient in supine position, left uterine displacement was done by 
placing a wedge under the right buttock. 
11. Remaining 8 mL of 0.125 % bupivacaine with 2 μg/mL fentanyl for 
group B or 8 mL of 0.1% ropivacaine with 2μg/mL fentanyl for group R 
was given epidurally and patient was shifted back to labour room. 
12. After 60 minutes or when pain recurred or after two segments was 
regressed whichever was earlier, 5mL (0.125% bupivacaine or 0.1% 
ropivacaine with fentanyl µg/mL) was given epidurally in presence of 
duty assistant professor. 
13. Left uterine displacement was maintained throughout the labour. 
14. Intermittent bladder catheterisation was done. 
15. Frequent vaginal examination was not encouraged throughout the labour. 
16. Oxytocin infusion was stopped before shifting patient to OT and during 
catheter insertion. It was then restarted after catheter insertion. 
17. Patient was educated that she would feel the uterine contractions as 
tightness without pain. Except pain, she can feel all other sensation.  At 
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the time of onset of second stage of labour, she may feel pain over 
perineum, inner thigh, anus or vagina.  
18. Full dose of 10 mL of (bupivacaine 0.125% / ropivacaine 0.1%) was 
administered regardless of previous dose at second stage, relieves the 
pain without affecting course of labour and this avoids further analgesia 
for episiotomy also. 
19. Obstetric management was decided by obstetricians. 
20. Continuous maternal and fetal monitoring was done and epidural catheter 
was removed six hours after delivery. 
MONITORING: 
1) Time of onset of analgesia. 
2) Assessment of sensory blockade. 
3) Assessment of motor blockade. 
4) Assessment of sedation. 
5) Duration of analgesia. 
6) Assessment of cardiovascular and respiratory system status. 
7) Complications or side-effects if any. 
8) Obstetric progress by partograph. 
9) Fetus monitoring by fetoscope, cardio tocograph. 
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1. Onset of Analgesia: 
Time taken for achieving visual analogue scale to become less than 3. The patient was 
asked to point to the position on the line between the faces to indicate how much pain they 
are currently feeling. The far left end indicates ‘No pain’ and the far right end indicates 
‘Worst pain ever’ 
 
2. Level of Sensory Blockade: 
The level of sensory blockade was assessed every 15 minutes using spirit cotton for 
loss of cold sensation in the midclavicular line bilaterally from the nipple to the pubic 
symphysis. 
3. Assessment of Motor Blockade: 
Assessed by modified Bromage Scale 
0 No motor blockade 
1 Unable to lift leg straight 
2 Unable to flex knees 
3 Unable to flex ankles 
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4. Assessment of Sedation: 
 
Sedation was assessed using 5- point scale 
 
Score Description 
0 Wide awake 
1 Drowsy 
2 Dozing, eyes shut intermittently 
3 Asleep 
4 Unarousable 
 
5. Duration of Analgesia: 
Time interval from the onset of analgesia till the return of painful 
contraction (VAS more than 3) or till regression of sensory level to below T12 
6. Assessment of Cardiovascular Status: 
Baseline values of maternal pulse rate and blood pressure was recorded, 
these parameters were again recorded after the block for every 5 minutes 
interval up to 20 minutes, then at 30th minute and thereafter every 30 minutes 
with each top up till delivery. Fetal heart rate was continuously monitored using 
a cardiotocograph. 
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7. Side effects of Drugs / Procedure: 
 Hypotension- fall in systolic BP to less than 100 mm Hg or 20% to 30% 
drop in systolic blood pressure (compared with baseline) 
 Bradycardia- pulse rate of less than 60 beats/ minute 
 Pruritus 
 Others (nausea, vomiting etc.) 
8. Progress of Labour: 
The progress of labour was observed closely after instituting block by 
partograph. 
The frequency and intensity of uterine contractions, dilation and 
effacement of cervix, descent of presenting part and the foetal heart rate was 
periodically recorded by the obstetrician. 
The requirement for instrumental deliveries or Caesarean section and 
their indications was also noted. 
9. Fetal Monitoring: 
 
The fetal heart rate is monitored by cardiotocograph. 
Rate less than 100/ minute was taken as bradycardia and rate of morethan 
160/minute was taken as tachycardia. 
At birth, the APGAR score of the neonate at 1 and the 5th minute  was 
used to assess the neonatal well being. Any neonate with an APGAR score of 
less than 7 was resuscitated with suctioning, mask ventilation and  intubation if 
needed and ventilated with 100% oxygen. 
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10. Patient Satisfaction Score: 
                    1-excellent 
                    2-good 
                    3-poor 
                                 
                                     STATISTICAL ANALYSIS 
The statistical analysis were done using SPSS (Statistical package for 
social sciences) version 17 for windows. The profile of the cases was compared 
with the treatment allocation in order to check if there was any significant 
difference. Descriptive statistics are presented as mean± 1SD. Component bar 
and line diagrams were drawn as and when required. Two sided independent 
student’s t tests to analyze continuous data and Chi-square test for association 
was used to compare categorical variables between treatment allocations. 
P<0.05 was considered as statistically significant 
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OBSERVATION AND RESULTS 
DEMOGRAPHIC DATA: 
AGE (in years) (student’s t test): 
 No. of cases Mean ± 
S.D(years) 
P Value 
Group B 30 21.97 ± 2.356 0.291 Group R 30 22.63 ± 2.484 
 
Mean age in group B was 21.97years with SD of 2.356. In group R mean 
age was 22.63years with SD of 2484. P value of 0.291 and was statistically 
insignificant. 
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WEIGHT (kg) and HEIGHT (cm) (student’s t test): 
 GROUP B GROUP R P VALUE 
Weight 
(mean±S.D)(kg) 
71.30 ± 5.484 71.53 ± 5.941 0.875 
Height 
(mean±S.D)(cm) 
160.23 ± 4.400 158.77 ± 5.117 0.239 
 
  
Mean weight in group B was71.30 kg with SD of 5.484. In group R mean 
weight was 71.53kg and SD of 5.941. P value of 0.875 and was statistically 
insignificant. 
Mean height in group B was160.23 cms with SD of4.400. In group R 
mean height was158.77cms and SD of 5.117. P value of 0.239 and was 
statistically insignificant. 
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CERVICAL DILATATION(cm) (student t test): 
Cervical dilatation(cm) GROUP B GROUP R 
mean±S.D 4.23±0.430 4.23±0.430 
P value 1.0 
 
Mean cervical dilatation in both groups was 4.23 cm with S.D of 0.430 and P 
value of 1.0 which was statistically insignificant. 
DURATION OF LABOUR (min) (student t test): 
Duration Active phase of first 
stage of labour 
Second stage of 
Labour 
Total duration 
Group B 171.97±19.089 31.30±5.240 203.77±19.856 
Group R 172.03±25.926 31.10±5.762 203.13±22.793 
P Value 0.991 0.889 0.909 
 
Mean duration of active phase of 1st stage of labour in group B 
was171.97 minutes with SD of19.089. In group R mean duration of active phase 
of 1st stage was172.03 minutes with SD of 25.926. P value of 0.991.Mean 
duration of 2nd stage of labour in group B was 31.30 minutes with SD of 5.240. 
In group R mean duration of 2nd stage was 31.10 minutes with SD of 5.762. P 
value of 0.889. Mean total duration of labour in group B was203.77 minutes 
with SD of19.856. In group R mean total duration of labour was 203.13minutes 
with SD of 22.793. P value of 0.909. All duration were statistically in 
significant. 
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Total number and volume of epidural bolus doses (top-up): (student test): 
 
 Total number of 
epidural bolus 
Total Volume of 
Epidural 
Drug(mL) 
Group B 4.33±0.547 33.33±4.011 
Group R 4.00±0.947 32.17±4.676 
P Value 0.100 0.102 
 
Mean of total number of epidural bolus doses used in group B was 
4.33with SD of 0.547. In group R Mean of total number of epidural bolus doses 
used was 4.00 with SD of 0.947. P value of0.100 and was statistically 
insignificant. 
Mean of total volume used for epidural analgesia in group B was 
33.33mL with SD of 4.011. In group R mean of total volume used for epidural 
analgesia used was32.17 mL and SD of 4.676. P value of 0.102 and was 
statistically insignificant. 
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TOTAL DOSE OF EPIDURAL FENTANYL (µg) (student t test): 
 Total Dose Of 
Fentanyl(µg) 
P Value 
 
0.304 
 
Group B 66.67±8.023 
Group R 64.33±9.353 
 
Mean of total dosage of fentanyl used in group B was 66.67 µg with SD 
of 8.023. In group R mean of total dosage of fentanyl used was 64.33µg with 
SD of 9.353. P value of 0.304 and was statistically insignificant. 
 
 
 
 
0
1
2
3
4
5
6
Group B Group R
Total number of 
epidural bolus 
0
10
20
30
40
50
Group B Group R
Total Volume of 
Epidural Drug 
77 
 
 
 
 
HEIGHT OF DERMATOME (Chi-square test): 
 T7 T8 T9 T10 P Value 
Group B 4(13.3%) 17(56.7%) 6(20.0%) 3(10.0%) 0.48 Group R 6(20.0%) 11(36.7%) 8(26.7%) 5(16.7%) 
 
Maximum dermatomal level of sensory blockade achieved in both groups 
was T7. 13.3% in group B and 20.0% in group R had T7 level.56.7 % in group 
B and 36.7 %  in group R had T8 level.10.0% in group B and 16.7% in group R 
achieved T10 level .20% in group B and 26.7% in group R achieved T9 level. P 
value was 0.48 and statistically insignificant. 
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BASELINE VAS (student's t test): 
 MEAN±S.D P VALUE 
GROUP B 9.70±0.466 0.19 
GROUP R 9.53±0.507  
 
Mean of baseline VAS in group B was 9.70and SD of 0.466. In group R 
mean of baseline VAS was 9.53 and SD of 0.507. P value of 0.19 and was 
statistically insignificant. 
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TIME TO VAS<3(sec)(student t test): 
 MEAN±S.D P VALUE 
GROUP B 111.10±17.197 0.104 GROUP R 105.27±8.828 
 
Mean of onset of analgesia (time to VAS <3) in group B was 111.10 
seconds and SD of 17.197. In group R mean of onset of analgesia was 105.27 
and SD of 8.828. P value of 0.104and was statistically insignificant. 
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Visual Analogue Score (VAS) (student's t test): 
VAS GROUP B GROUP R P VALUE 
5 min 1 1  
10 min 1 1  
15min 1.03±0.183 1.03±0.183 1.0 
30min 1.07±0.254 1.03±0.183 0.56 
60min 1.13±0.346 1.23±0.430 0.32 
90min 1.03±0.183 1.23±0.504 0.46. 
120min 1.30±0.702 1.37±0.615 0.69 
150min 1.47±0.819 1.30±0.466 0.33 
180min 1.43±0.728 1.30±0.466 0.22 
210min 1.31±0.604 1.07±0.267 0.06 
240min 1 1  
270min 1 1  
 
The above table shows VAS score changes. From the above table p-value 
of both the groups shows no statistically significant differences. 
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PULSE RATE (beats/min): 
PULSE RATE
  
GROUP B GROUP R P VALUE 
Base line 104.83±6.675 103.67±5.567 0.465 
5 min 96.40±6.317 96.53±5.563 0.931 
10 min 92.67±7.622 93.33±5.944 0.707 
15min 86.23±5.740 90.10±6.133 0.14 
30min 83.13±5.513 87.10±5.573 0.007 
60min 81.77±5.882 84.93±6.258 0.14 
90min 81.33±5.320 83.00±5.645 0.244 
120min 79.70±5.472 81.40±5.733 0.245 
150min 77.90±6.071 80.60±5.123 0.06 
180min 77.80±6.042 79.03±4.560 0.376 
210min 77.84±6.650 77.69±4.380 0.925 
240min 84.00±7.937 82.75±2.866 0.625 
270min 80.80±5.431 82.45±6.133 0.233 
 
The above table shows Mean Pulse rate changes. . From the above table 
p-value of both the groups shows no statistically significant differences. 
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SYSTOLIC BP (mm Hg): 
systolic BP GROUP B GROUP R P VALUE 
Base line 126.87±10.988 127.20±7.645 0.987 
5 min 119.77±9.016 117.20±9.065 0.276 
10 min 118.80±9.675 114.00±8.769 0.49 
15min 118.57±11.503 114.10±10.192 0.117 
30min 119.27±11.307 115.07±11.197 0.15 
60min 116.90±11.109 116.00±10.687 0.75 
90min 114.73±10.576 115.13±8.893 0.875 
120min 115.47±10.543 114.63±8.880 0.742 
150min 117.40±9.496 114.87±8.581 0.410 
180min 115.37±9.038 113.17±7.670 0.314 
210min 116.28±7.630 114.17±8.066 0.557 
240min 120.73±7.630 118.09±7.145 0.267. 
270min 119.27±11.307 114.00±8.769 0.56 
 
The above table shows Mean Systolic BP changes.  From the above table 
p-value of both the groups shows no statistically significant differences. 
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DIASTOLIC BP (mm Hg): 
Diastolic BP GROUP B GROUP R P VALUE 
Base line 78.53±6.678 76.30±5.627 0.288 
5 min 72.47±5.882 72.10±5.333 0.801 
10 min 72.13±5.519 71.97±5.518 0.907 
15min 69.77±5.418 71.00±4.668 0.349 
30min 71.57±4.629 71.27±4.209 0.794 
60min 70.40±5.001 72.03±6.446 0.277 
90min 71.03±6.739 72.03±5.468 0.530 
120min 70.07±6.203 71.53±5.544 0.338 
150min 71.97±7.595 69.47±4.240 0.121 
180min 71.43±6.140 69.37±4.156 0.132 
210min 71.44±6.104 70.17±4.509 0.421 
240min 72.55±4.741 72.36±4.884 0.930 
270min 71.57±4.629 71.27±4.209 0.794 
 
The above table shows Mean Diastolic BP changes. From the above table 
p-value of both the groups shows no statistically significant differences. 
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SATURATION (%): 
Saturation GROUP B GROUP R P VALUE 
Base line 99.43±0.728 99.57±0.504 0.413 
5 min 99.27±0.691 99.33±0.606 0.693 
10 min 99.27±0.691 99.27±0.691 0.616 
15min 99.27±0.691 99.23±0.728 0.693 
30min 99.27±0.691 99.27±0.691 0.172 
60min 99.27±0.691 99.23±0.728 0.111 
90min 98.83±0.085 98.23±0.504 0.672 
120min 99.83±0.834 99.20±0.714 0.073 
150min 99.03±0.765 99.20±0.714 0.178 
180min 99.13±0.819 99.50±0.682 0.650 
210min 99.32±0.557 99.38±0.576 0.735 
240min 99.50±.527 99.30±.823 0.526 
 
The above table shows mean saturation changes. From the above table p-
value of both the groups shows no statistically significant differences. 
 
 
64
66
68
70
72
74
76
78
80
GROUP B
GROUP R
85 
 
 
 
 
MOTOR BLOCKADE: 
MOTOR 
BLOCKADE 
0 1 2 3 
GROUP B 20(66.7%) 10(33.3%) 0 0 
GROUP R 26(86.7%) 4(13.3%) 0 0 
P VALUE 0.67 
 
20(66.7%) of patients in group B and 26(86.7%) of patients in group R 
had no motor blockade.10 patients (33.3%) in group B and 4(13.3%) patients in 
Group R had grade 1 Bromage (minimal) motor blockade. No patient in any 
groups was developed grade 2 or 3 motor blockade P value of 0.67, which is 
statistically insignificant. 
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Above line diagram showed that maximum motor blockade (grade 1 Bromage) 
has occurred during first stage of labour and immediately following bolus dose. 
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SEDATION: 
Sedation score GROUP B GROUP R P VALUE 
Base line 0±0 0±0 1.000 
5 min 0.27±0.450 0.27±0.450 1.000 
10 min 0.27±0.450 0.27±0.450 1.000 
15min 0.27±0.450 0.27±0.450 1.000 
30min 0.27±0.450 0.27±0.450 1.000 
60min 0.27±0.450 0.27±0.450 1.000 
90min 0.23±0.430 0.17±0.379 0.527 
120min 0.27±0.450 0.27±0.450 1.000 
150min 0.23±0.430 0.17±0.379 0.527 
180min 0.23±0.430 0.17±0.379 0.527 
210min 0.23±0.430 0.17±0.379 0.527 
240min 0.27±0.450 0.27±0.450 1.000 
 
The above table shows Sedation score in both groups. From the above table p-
value of both the groups shows no statistically significant differences. 
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FETAL HEART RATE (beats/min): 
Fetal heart rate GROUP B GROUP R P VALUE 
Base line 139.63±7.137 139.93±6.596 0.866 
5 min 138.27±7.904 138.57±6.157 0.870 
10 min 138.27±7.244 139.63±5.933 0.427 
15min 138.27±7.400 138.30±4.998 0.984 
30min 140.73±8.191 139.10±5.756 0.375 
60min 138.87±7.440 139.90±4.859 0.527 
90min 141.00±6.863 140.93±5.589 0.967 
120min 139.97±8.315 139.30±4.519 0.701 
150min 140.70±6.508 139.37±5.986 0.412 
180min 140.10±7.703 137.43±5.322 0.124 
210min 140.10±7.703 138.00±5.381 0.158 
240min 138.82±6.809 135.70±4.057 0.224 
 
Fetal heart rate changes in both groups were within normal limits. 
From the above table p-value of both the groups shows no statistically 
significant changes. 
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OUTCOME: 
OUTCOME GROUP B GROUP R P VALUE 
SPONTANEOUS 
VAGINAL 
DELIVERY 
29(96.7%) 29(96.7%)  
 
             1.0 
FORCEPS 1(3.3%) 1(3.3%) 
EMERGENCY 
LSCS 
0 0 
 
In both groups all babies delivered by normal vaginal delivery except two 
babies were delivered by forceps delivery. Both of them were secondary to poor 
maternal efforts. No other case underwent caesarean section. 
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APGAR SCORE: 
APGAR SCORE GROUP B GROUP R P VALUE 
1 MIN 7.57±0.504 7.57±.0504 1.000 
5 MIN 8.57±0.504 8.87±0.346 .009 
 
At 1 minute in group B mean of APGAR score was 7.57 and SD was 
0.504. In group R mean was APGAR score 7.57 and SD was 0.504. P value of 
1.0 and was statistically insignificant.  
At 5 minutes in group B mean of APGAR score was 8.57 and SD was 
0504. In group R mean was APGAR score 8.87 and SD 0.346. P value of 0.009 
and was statistically insignificant. 
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COMPLICATIONS: 
COMPLICATION GROUP B  GROUP R P VALUE 
PRURITUS 22(73.3%) 20(66.7%) 0.5 
NONE 8(44.4%) 10(55.6%) 
 
Pruritus was seen in both the groups. In group B (73.3%) and group R (66.7%). 
 
 
 
PATIENT SATISFACTION: 
 
 
 
 
All parturients in both the group experience excellent analgesia during 
labour till delivery. 
 
 
PATIENT 
SATISFACTION 
SCORE 
GROUP B GROUP R 
1 30(100%) 30(100%) 
2 0 0 
3 0 0 
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DISCUSSION 
Neuraxial method provides excellent and satisfactory analgesia without 
compromising maternal and fetal safety hence it is considered till now as a gold 
standard technique for providing labour analgesia15. 
 Use of low concentration local anaesthetic solution preferably blocks ‘C’ 
fibres which transmits pain without causing motor blockade that otherwise may 
affect outcome and course of labour. But using ultra minimal concentration of 
local anesthetics will result in inadequate analgesia, if it is used alone. Addition 
of opioid will decrease the MLAC (minimum local anaesthetic concentration) of 
local anesthetics used and makes it effective for labour analgesia. 
              Many studies showed that ropivacaine is 60% as potent as that of 
bupivacaine. There have been many studies compared equal concentration of 
drugs64, 66, 69, 81 (0.125% bupivacaine vs0.125% ropivacaine) and equi-potent 
concentration72, 73 of both drugs (0.1% bupivacaine vs. 0.15% ropivacaine). 
Most of the studies proved that that both drugs didn’t differ significantly except 
that ropivacaine had less motor blockade on prolonged infusion. 
             In our study, we instituted labour analgesia with combined spinal 
epidural analgesia technique in 60 parturients .Each group had 30 parturients. In 
both the groups analgesia was initiated with intrathecal injection of fentanyl 
25μg. Epidural catheterization was done following spinal analgesia. Epidural 
analgesia was initiated with 10 mL of 0.125% bupivacaine with fentanyl 
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2μg/mL in group B and with 10 mL 0.1% ropivacaine with fentanyl 2μg/mL in 
group R.   
We compared the quality of analgesia by using VAS score during labour 
analgesia and patient’s satisfaction at the end of delivery in both the groups. 
             We also compared the other parameters like onset, degree and duration 
of analgesia, sensory blockade and motor blockade, the duration of first and 2nd 
stage of labour, progress and outcome of labour, fetal heart rate changes, 
outcome of newborn by APGAR score and complications between both the 
groups. 
There were no difference between two groups with respect to age, height 
and weight. 
             Mean baseline VAS in group B was 9.7 with S.D of 0.466 and in group 
R mean baseline VAS was 9.53 with S.D of 0.507. P value of 0.19 and it was 
statistically insignificant. 
            Labour analgesia was initiated in both groups between 4-5 cms of 
cervical dilatation. Mean cervical dilatation in both groups was 4.23cm with 
S.D of 0.430 .P value of 1.0 which was statistically insignificant. 
            In a randomised study, Lyons et al 40compared needle through needle 
with separate needle CSE in 100 parturients undergoing caesarean section and 
Casati et al compared the same techniques in 120 non obstetric patients. They 
observed that less hypotension, lower incidence of spinal failure rate and it took 
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lesser time to perform in separate needle groups. Hence we used separate needle 
CSE technique in our study. 
              Opioid alone is enough for providing pain relief during early latent 
stage. But soon after spinal injection, low dose bupivacaine 0.03-0.0625% 
epidural infusion with opioid can started.  Alternatively, epidural can be started 
whenever necessary67. 
              CSE analgesia often initiated with intrathecal opioid (fentanyl 25µg or 
sufentanyl 5µg) in early latent phase with cervical dilatation less 4-5 cm 
followed by epidural catheter placement in healthy nulliparous women. 
Addition of local anesthetics to opioid intrathecally is unnecessary for achieving 
complete spinal analgesia especially in early stage will result in hypotension 
and profound motor blockade particularly if it is followed by an epidural 
injection of local anesthetics60, 61. 
             In our study, we initiated labour analgesia with intrathecal fentanyl 25 
µg followed by epidural catheter placement in L3-L4/L2-L3 space and catheter 
tip fixed at T12/L1. Ten min after spinal analgesia group B received ten mL of 
0.125% bupivacaine with fentanyl 2µg/mL and group R received ten mL of 
0.1% ropivacaine with fentanyl 2µg/mL. 
               Mean onset of analgesia (time to VAS <3)  was 111.10 sec with S.D of 
17.197 in group B and mean onset of analgesia was105.27 sec with S.D of 
8.828.P value of 0.104 was statistically insignificant. There is no significant 
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difference between two groups with respect to onset of analgesia since both 
groups were initiated with intrathecal fentanyl 25µg. 
               These results were consistent with Meister et al66 compared 0.125% 
bupivacaine and 0.125% ropivacaine with fentanyl. They found that mean VAS 
score which were around 9 in bupivacaine and 8 in ropivacaine  came down to 
0.4 and 0.3 respectively post epidural. Fernandez et al72 compared 0.0625% 
bupivacaine with 0.1% ropivacaine with fentanyl. There was no significant 
difference between two groups with to onset of pain relief.           
              Maximum dermatomal level of sensory blockade achieved in both 
groups was T7. 13.3% in group B and 20.0% in group R had T7 level.56.7 % in 
group B and 36.7 %  in group R had T8 level.10.0% in group B and 16.7% in 
group R achieved T10 level .20% in group B and 26.7% in group R achieved T9 
level. P value was 0.48 and statistically insignificant. 
            This was comparable to the level achieved by Owen et al 64and 
Guisasola72 et al. 
            In a Halpern et al82, a Meta analytic study compared ropivacaine and 
bupivacaine in equal concentration in labour analgesia. He found that 19 out of 
23 studies supported ropivacaine had minimal blockade and 5 out of those 
studies were statistically significant. 
              Incidence of motor block was less in many studies and it was 
statistically significant in many studies (Gautier et al, Fischer et al, Meister et al, 
Campbell et al, Fine gold et al)64, 66,67,70. 
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             In our study, 20(66.7%) of patients in group B and 26(86.7%) of 
patients in group R had no motor blockade.10 patients (33.3%) in group B and 
4(13.3%) patients in  Group R had grade 1 Bromage (minimal) motor blockade. 
No patient in any groups was developed grade 2 or 3 motor blockade P value of 
0.67, which is statistically insignificant. Maximum motor blockade (grade 1 
Bromage) has occurred during first stage of labour and was seen immediately 
following bolus dose. 
            There were no statistically significant differences in blood pressure, 
pulse rate, saturation in both the groups. 
              No statistically significant differences in Sedation score of both groups. 
Some patients showed mild drowsiness (score 1) mainly due to effective pain 
relief. 
             Fetal heart rate changes in both groups were within normal limits. P 
value of both the groups shows no statistically significant changes. 
             In both the groups VAS was maintained with less than 3.In most cases 
VAS 3 usually coincide with the onset of 2nd stage of labour. Repeating the 10 
mL of bupivacaine maintained the analgesia. 
           Mean duration of active phase of 1st stage of labour in group B 
was171.9±19.089 minutes and172.03 ± 25.926 minutes in group R. Mean 
duration of 2nd stage of labour in group B was 31.30±5.240 minutes and  in 
group R it was 31.10 ±5.762 minutes. Mean total duration of labour in group B 
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was203.77 ±19.856 minutes and in group R it was 203.13± 22.793minutes.  All 
durations were statistically insignificant 
            Our results were correlated well with many studies (Feranandez2001, 
Owen 20024, Boselli 2003, Halpern 2003)72, 64,76,77,82. In contrast Lee et al 
200275, found that the bupivacaine group had longer first stage of labour than 
ropivacaine group. However they concluded that the difference may be of 
limited clinical significance. 
           In our study CSE is associated with more rapid cervical dilatation and 
shorter duration of labour. This result was consistent with studies conducted by 
Amit.G.Bhagwat et al47 and Lawrence C Tsen et al46. 
           Mean of total number of epidural bolus doses used in group B was 
4.33with SD of 0.547. In group R Mean of total number of epidural bolus doses 
used was 4.00 with SD of 0.947. P value of0.100 and was statistically 
insignificant. 
           Mean of total volume used for epidural analgesia in group B was 
33.33mL with SD of 4.011. In group R mean of total volume used for epidural 
analgesia used was32.17 mL and SD of 4.676. P value of 0.102 and was 
statistically insignificant. 
   There was no difference between two groups in volume requirements. 
            During second stage, all parturients in our study required ten mL of local 
anaesthetic bolus for effective pain relief during episiotomy. This was not 
influenced by position of patient and mainly depends on volume.  
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            Merry A Fet al, Park WY et al, Erdemir HA et al studies showed that 
inconsistent results with position of patient during drug administration but by 
increasing the volume of drug83, 84,85 during second stage of labour. 
            Mean of total dosage of fentanyl used in group B was 66.67 µg with SD 
of 8.023. In group R mean of total dosage of fentanyl used was 64.33µg with 
SD of 9.353. P value of 0.304 and was statistically insignificant. 
              Most studies showed that incidence of emergency caesarean delivery 
were less with CSE technique when compared to conventional epidural48, 53. 
Risk of caesarean delivery does not increased by neuraxial techniques and also 
by time of initiation of labour analgesia in latent phase (cervical dilatation 4 
cm)55 . 
            In both groups all babies delivered by normal vaginal delivery except 
two babies were delivered by forceps delivery. Both of them were secondary to 
poor maternal efforts. No other case underwent caesarean section. 
            The recent Cochrane review 81which compared epidural analgesia with  
inhalational and intravenous analgesia (mainly opioid)  and observed that there 
was less fetal acidosis and less nalaxone administration in babies born to 
mothers having labour epidural analgesia. 
             Beilin and Halpern in 201065, 82 did a focused review with various 
studies that compared bupivacaine and ropivacaine and concluded that there 
was no evidence that neonatal outcome is adversely affected when ropivacaine 
or bupivacaine is used for labour analgesia. 
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            In our study, at 1 minute in group B mean of APGAR score was 7.57 
and SD was 0.504. In group R mean was APGAR score 7.57 and SD was 0.504. 
P value of 1.0 and was statistically insignificant.  
            At 5 minutes in group B mean of APGAR score was 8.57 and SD was 
0504. In group R mean was APGAR score 8.87 and SD 0.346. P value of 0.009 
and was statistically insignificant. 
           Yeh HM, Chen LK, Lin CJ. et al concluded that prophylactic 
Ondansetron administration reduces the incidences of pruritus induced by 
intrathecal morphine86. 
          In our study, Pruritus was seen in both the group B (73.3%) and group R 
(66.7%). In most of womens it was self limiting and got settled within hour of 
fentanyl administration. Some responded well to Ondansetron 4 mg IV. 
        No other complications were seen during labour analgesia. 
        RE Collis, DWL Davies concluded that overall satisfaction was greater in 
CSE group than conventional epidural because of CSE produces rapid onset of 
analgesia14, 43. 
        In our study, all parturients in both the group experience and gave 
satisfaction score of (=1) excellent analgesia during labour till delivery. 
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SUMMARY 
         Neuraxial analgesia remains the safest and most commonly performed 
technique amongst all available methods of labour analgesia. Among neuraxial 
technique, Combined Spinal Epidural analgesia is the most commonly preferred 
method nowadays because of its rapid action and good quality of analgesia. 
         Despite its advantages and proven benefits, it hasn’t become popular 
choice in developing countries like India because of myths like increased risk of 
operative delivery and instrumental delivery, increased risk of motor blockade 
and hypotension which affects the progression of labour. 
          By using low dose concentration of local anesthetics with opioid produces 
better quality of analgesia without adverse effects. 
         In our study, we compared combined spinal epidural technique using 
equal concentration of bupivacaine (0.125%) and ropivacaine (0.1%) for quality 
of analgesia. To initiate analgesia we used intrathecal fentanyl 25 µg in both the 
groups and we also used fentanyl 2µg/mL in epidural preparation of 
bupivacaine and ropivacaine to improve quality of analgesia in both the groups. 
          Both the groups were comparable in age, height, weight, parity and time 
of initiation of labour analgesia. 
         Quality of analgesia was excellent in both the groups which were assessed 
by patient’s satisfaction at the end of delivery and effective analgesia 
throughout the progress of labour till delivery. Onset of analgesia was 
comparable in both the groups. It also shortens duration of labour which was 
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augmented by obstetricians as a part of active management of labour. Nearly all 
parturients in both the groups were required ten mL of bupivacaine or 
ropivacaine for effective pain relief during second stage of labour. All 
parturients in both the groups delivered baby by normal vaginal delivery except 
two babies with each in a group were delivered by forceps which was secondary 
to poor maternal efforts.  No other case underwent operative delivery.  
              Out of sixty parturients, 10 patients (33.3%) in group B and 4(13.3%) 
patients in Group R had grade 1 Bromage (minimal) motor blockade.  P value 
(0.67) which was statistically insignificant. No patient in any groups was 
developed grade 2 or 3 motor blockade at any time during the course of labour. 
Maximum motor blockade (grade 1 Bromage) has occurred during the first 
stage of labour and was seen immediately following the first epidural bolus dose 
that doesn’t affect the progression of labour. Except pain and temperature, all 
other sensations were intact. No significant changes in epidural bolus, volume 
of drugs used epidurally and dosage of fentanyl used were noted.  
                 No significant changes were noted in maternal vital signs, sedation, 
fetal heart rate and APGAR score. Pruritus was seen in both the group B 
(73.3%) and group R (66.7%)  which was mild and self limiting. 
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DRAWBACKS OF OUR STUDY: 
 
We relied upon APGAR score for assessing the neuro behavioural 
outcome of the baby. 
          We didn’t measure umbilical cord pH to assess the effects of drugs on 
acid base status of fetus due to financial constraints. 
           We didn’t measure the amount of oxytocin used in our study. 
 
 
 
 
                                               
 
 
 
 
 
 
 
 
\ 
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                                                 CONCLUSION 
       
               The observation of this study shows that both bupivacaine 0.125% and 
ropivacaine 0.1% administered epidurally as a part of combined spinal epidural 
technique following intrathecal 25µg provides equal and effective analgesia. 
Duration of labour was not prolonged rather combined spinal epidural analgesia 
decreases the duration of labour. Patient satisfaction, level of sensory blockade, 
mode of delivery, duration of labour, neonatal outcome and complications are 
comparable between both the groups. Bupivacaine group had relatively more 
motor blockade which was grade 1 Bromage when compared to ropivacaine 
group but that was not statistically significant. Maximum motor blockade of 
grade 1 Bromage was seen during first stage of labour especially immediately 
after first epidural bolus dose which doesn’t affect the progress of labour. But 
the observation of this study with respect to motor blockade was not statistically 
significant which needs further future studies in large scale. 
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S.No
PR Base Line
PR 5'
PR 10'
PR 15'
PR 30'
PR 60'
PR 90'
PR 120'
PR 150'
PR 180'
PR 210'
PR 240'
PR 270'
PR 300'
SBP Baseline
DBP Baseline
SBP 5'
DBP5'
SBP 10'
DBP10'
SBP 15'
DBP15'
SBP 30'
DBP30'
SBP 60'
DBP60'
SBP 90'
DBP90'
SBP 120'
DBP120'
SBP 150'
DBP150'
SBP 180'
DBP180'
SBP 210'
DBP210'
SBP 240'
DBP240'
SBP 270'
DBP270'
SBP 300'
DBP300'
1
10
3
98
85
88
83
87
86
78
76
80
86
88
11
8
88
12
6
78
12
0
78
12
6
76
11
8
72
11
4
72
11
6
82
12
6
84
12
2
84
12
6
82
11
2
74
11
4
74
2
11
0
92
89
88
86
85
82
78
74
73
77
11
4
72
10
8
70
10
2
64
10
0
62
10
2
64
11
2
70
10
2
64
12
0
68
11
0
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11
2
68
12
4
74
3
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0
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2
88
84
82
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72
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84
10
7
68
11
2
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11
8
68
11
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11
8
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10
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64
12
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13
0
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10
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0
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S.No
MB 5'
MB 10'
MB 15'
MB 30'
MB 60'
MB 90'
MB 120'
MB 150'
MB 180'
MB 210'
MB 240'
MB 270
MB 300'
MAXIMUM 
MOTOR 
BLOCKADE
SEDATION 
Baseline
SEDA 15'
SEDA 30'
SEDA 60'
SEDA 90'
SEDA 120'
SEDA 150
SEDA 180'
SEDA 210'
SEDA 240'
SEDA 270'
SEDA 300'
sp02baseline
SpO2 15'
SpO2 30'
SpO2 60'
SpO2 90'
SpO2 120'
SpO2 150'
SpO2 180'
SpO2 210'
SpO2 240'
SpO2 270'
SpO2 300'
FHR Baseline
FHR 5'
FHR 10'
FHR 15'
FHR 30'
FHR 60'
FHR 90'
FHR 120'
FHR 150'
FHR 180'
FHR 210'
FHR 240'
FHR 270'
FHR 300'
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
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10
0
10
0
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0
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10
0
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0
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Ag
e
IP NO
Height in (cm)
Weight (in kg)
parity
Cervical Dilatation
Duration of Active 
Stage1st (min)
2nd stage(min)
Total duration till 
delivery(min)
no.of epidural 
bolus doses
Total Volume of EA 
used(ml)
Total Dosage of 
Ropivacaine(mg)
epidural 
fentanyl(mcg)
Time to VAS(sec)
Height of 
dermatomal level
VAS Baseline
VAS 5'
VAS 10'
VAS 15'
VAS 30'
VAS 60'
VAS 90'
VAS 120'
VAS 150'
VAS 180'
VAS 210'
VAS 240'
VAS 270'
VAS 300'
Outcome
APGAR Score 1'
APGAR Score 5'
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Patient Satisfaction
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              COMBINED SPINAL EPIDURAL LABOUR ANALGESIA 
COMPARISON OF EPIDURAL 0.125% BUPIVACAINE WITH 
FENTANYL VERSUS 0.1% ROPIVACAINE WITH FENTANYL 
 
PROFORMA 
NAME OF PATIENT:                                                                      CASE NO: 
AGE:                                                                                               STUDYGROUP: 
UNIT:                                                                                               HEIGHT: 
EDUCATIONAL STATUS:                                                              WEIGHT:   
ADDRESS:                                                                                      GRAVIDA: 
                                                                                                         ASA-PS: 
OCCUPATION: 
DATE &TIME OF ADMISSION: 
DATE AND TIME OF STUDY: 
EXAMINATION OF PATIENT: 
    PR:              BP:                      RR:             CVS:                   RS:                      
FHR: 
PV FINDINGS: Dilatation-                        Station-                 Membrane- 
                         Effacement-                      position-             
INVESTIGATIONS:  
Hb-               RBS-                       BLOOD GP-                     BT,CT-             U/E- 
PRELOADING: 
SPINAL:  TIME- 
                 TECHNIQUE- 
                  DOSE & DRUG- 
                 ONSET OF ANALGESIA- 
                 DURATION OF ANALGESIA- 
EPIDURAL:TIME-  
                    TECHNIQUE- 
                    TEST DOSE- 
TOTAL NO. OF EPIDURAL TOPUPS:- 
AMOUNT OF DRUG DELIVERED PER HOUR 
 LOADING 1hr 2hr 3hr 4hr 5hr 6hr 7hr 8hr TOTAL 
ROPIVACAINE/ 
BUPIVACAINE           
FENTANYL           
MODE OF DELIVERY: 
LABOUR NATURAL: 
EPISIOTOMY: 
EPISIOTOMY PAIN:               YES/NO 
INSTRUMENTAL PAIN: 
         OUTLET FORCEPS/           LMC FORCEPS/          VACUUM DELIVERY 
          EPISIOTOMY PAIN:YES/NO 
CAESERIAN SECTION 
DURATION OF LABOUR:   I STAGE – 
                                             II STAGE – 
                                            III STAGE – 
APGAR SCORE : 1 MIN-                    5 MIN- 
COMPLICATIONS 
          URINARY RETENTION                                    MATERNAL BRADYCARDIA 
          MATERNAL HYPOTENSION                           PRURITUS 
          BACKACHE                                                      RESPIRATORY DEPRESSION 
          INADEQUATE ANALGESIA                             NAUSEA/VOMITING  
          DROWSINESS/SEDATION                               RIGORS/OTHERS 

                                              PATIENT CONSENT FORM 
 
COMBINED SPINAL EPIDURAL LABOUR ANALGESIA 
COMPARISON OF EPIDURAL 0.125% BUPIVACAINE WITH 
FENTANYL VERSUS 0.1% ROPIVACAINE WITH FENTANYL 
 
Study centre :   GOVT. KILPAUK MEDICAL COLLEGE HOSPITAL, CHENNAI. 
Patients Name  : 
Patients Age  : 
Identification Number        : 
   Patient may check (     ) these boxes 
a. I confirm that I have understood the purpose of procedure for the above study. I have the 
opportunity to ask question and all my questions and doubts have been answered to my 
complete satisfaction. 
 
b. I understand that my participation in the study is voluntary and that I am free to withdraw at any 
time without giving reason, without my legal rights being affected. 
 
c. I understand that sponsor of the clinical study, others working on the sponsor’s behalf, the 
ethical committee and the regulatory authorities will not need my permission to look at my 
health records, both in respect of current study and any further research that may be conducted 
in relation to it, even if I withdraw from the study I agree to this access. However, I understand 
that my identity will not be revealed in any information released to third parties or published, 
unless as required under the law. I agree not to restrict the use of any data or results that arise 
from this study. 
 
d. I agree to take part in the above study and to comply with the instructions given during the 
study and faithfully cooperate with the study team and to immediately inform the study staff if I 
suffer from any deterioration in my health or well-being or any unexpected or unusual 
symptoms. 
 
e. I hereby consent to participate in this study. 
 
f. I hereby give permission to undergo complete clinical examination and diagnostic tests 
including hematological, biochemical, radiological tests. 
Signature/thumb impression:    
Patients Name and Address:                      Place:   Date: 
 
Signature of investigator :    
Study investigator’s Name :                                  Place:   Date: 
ந ோயோளி தகவல் தோள் 
 
 
வலியில்லோ பிரசவ முறைக்கோக கம்றபண்டு ஸ்றபனல் எபிடூரல்  முறையில் இரு 
குழுக்களுக்கும்  தண்டுவடபகுதியில் பபன்டறனல் என்ை மருந்து 25 றமக்நரோகிரோம் 
அளிக்கப்படும்.ஒரு குழுவுக்கு  தண்டுவடபகுதியின் பவளிப்புைம் எபிடூரல் பகுதியில் 0.125%  
பியூப்பிவோக்பகய்ன் 10 மில்லி லிட்டர் மற்றும் பபன்டறனல் 20 றமக்நரோகிரோம்  மருந்து 
அல்லது 0.1% Nuhப்பிவோக்பகய்ன் 10 மில்லி லிட்டர் மற்றும் பபன்டறனல் 20 றமக்நரோகிரோம் 
மருந்து அளிக்கப்படும் ஆய்வில்பக்கவிறளவுகள் மிகக் குறைவோகவும்,உடனடியோக வலி 
 ிவோரணம் கிறடக்கவும் உதவும் மருந்தின் குறைந்த அளறவ கண்டைியவும், ந ோயோளியின் 
திருப்திறய அைியவும் பயன்படுத்தப் படுகிை ஒப்படீ்டு ஆய்வு.  
 
ஆரோய்ச்சியின் ந ோக்கமும்,ஆதோரங்களும்: 
 
ஒரு தோய்றமயின் சிைந்த தருணம் என்பது ஆநரோக்கியமோன குழந்றதறய பபற்றுக் பகோள்ளும் 
தருணம்தோன்.அநத குழந்றதறய வலியின்ைி,நவதறனயின்ைி ,இன்முகத்துடன் இந்த உலகத்திற்கு 
வரநவற்பது என்பது கண்டிப்போக அறத விட சிைந்த தருணமோகத்தோன் இருக்க முடியும்.  ஆய்வுகளின் 
படி பிரசவவலி என்பது புற்றுந ோய் கட்டியினோல் வரக்கூடிய வலிக்கு சமமோனதோகும். உங்கள் 
விரல்கறள மயக்க மருந்தின்ைி கதை ,கதை பவட்டி எடுப்பறத நயோசித்துப் போருங்கள். பிரசவ 
வலியோனது அதறன விட அதிக நவதறன தரக்கூடியது. பிரசவ வலியின் கோரணமோக தோயின் இருதய 
துடிப்பு, சுவோசம் நபோன்ைவற்ைில் ஏற்படும் மோற்ைங்கள், சில சமயம் தோயின் உடல்  லத்துக்கு 
மட்டுமன்ைி, நசய்க்கு கிறடக்க  நவண்டிய பிரோணவோயு,  ஞ்சுக்பகோடியின் வழியோக பசல்லும் ரத்த 
ஓட்டத்றதயும் குறைத்து ஆபத்தோன  ிறலக்கு பகோண்டு பசல்லும்.ஆனோல்  
சமூக,மத,குடுமப,கலோச்சோர கட்டுப்போடுகளின் படி பிரசவ வலிபயன்பது தவிர்க்க 
முடியோதது,ஒவ்பவோரு பபண்ணும் தன் வோழ்வில் கண்டிப்போக அனுபவிக்க நவண்டும் என்ை எழுதப் 
படோத விதியுள்ளது. 
             
  நமறல ோடுகளிலும்,  மது ஊரில் சில தனியோர் மருத்துவமறனகளிலும் வலியில்லோமல் 
சுகபிரசவம் போர்க்க விரும்பும் தோய்மோர்களுக்கு அந்த வோய்ப்பு வழங்கப் படுகிைது.வலியில்லோ பிரசவ 
முறையில் பிரசவ வலியின் கோரணமோக தோயின் இருதய துடிப்பு, சுவோசம் நபோன்ைவற்ைில் ஏற்படும் 
மோற்ைங்கள் கட்டுப்படுத்தப் படுகின்ைது. இது தோய்,நசய் இருவருககும்  ிறைவோன  லத்றத 
அளிக்கின்ைது. இப்படி வலியில்லோமல் சுகபிரசவம் போர்க்க  ிறைய வழிமுறைகள் உள்ளன.அப்படி 
பயன்படுத்தப்படும் வழிமுறைகளில் பக்கவிறளவுகள் மிகக் குறைவோகவும்,உடனடியோக வலி 
 ிவோரணம் கிறடக்கவும் பயன்படுத்தப்படும் முறைதோன் கம்றபண்டு ஸ்றபனல் எபிடூரல் 
முறை.இந்த முறையில் உங்களுக்கு முதுகுப்பகுதியில்  தண்டுவடபகுதியிலும், அதன் பவளிப்புைம் 
எபிடூரல் பகுதியில் மருந்துகள் அளிக்கப்படும்.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ஆய்வு முறை: 
         
   இதில்  ீங்கள் இரு குழுக்களோக பிரிக்கப் படுவரீ்கள்.இதில் இரு குழுக்களுக்கும் தண்டுவடபகுதியில் 
பபன்டறனல் என்ை மருந்து 25 றமக்நரோகிரோம் அளிக்கப்படும்.உங்களில் ஒரு குழுவுக்கு  
தண்டுவடபகுதியின் பவளிப்புைம் எபிடூரல் பகுதியில் 0.125 % பியூப்பிவோக்பகய்ன் 10 மில்லி லிட்டர் 
மற்றும் பபன்டறனல் 20 றமக்நரோகிரோம்  மருந்து அல்லது 0.1% Nuhப்பிவோக்பகய்ன் 10 மில்லி லிட்டர் 
மற்றும் பபன்டறனல் 20 றமக்நரோகிரோம்  மருந்து அளிக்கப்படும். நமற்கூைபட்ட மருந்துகளும், அதன் 
அளவுகளும் போதுகோப்போனறவபயன பல்நவறு ஆய்வுகள் மூலம் உறுதி பசய்யப்பட்டுள்ளன.இந்த 
ஆய்வோனது பக்கவிறளவுகள் மிகக் குறைவோகவும்,உடனடியோக வலி  ிவோரணம் கிறடக்கவும் 
உதவும் மருந்தின் குறைந்த அளறவ கண்டைியவும், ந ோயோளியின் திருப்திறய அைியவும் 
பயன்படுத்தப் படுகிைது, இந்த ஆய்வுக்கு முன்னரும், ஆய்வின் நபோதும், அதற்கு பின்னரும் தோய்,நசய் 
இருவரது உடல் ிறலயும் பதோடர்ச்சியோக மிகச் சிைந்த முறையில் கண்கோணிக்கப் படும். 
 
உண்டோகக்கூடிய இடர்கள்: 
         
 அறனத்து மயக்க மருந்து மற்றும் மயக்க மருந்துவ முறைகளுடன் இருப்பது நபோலநவ இந்த 
முறையிலும் சில எதிர்போரோ இடர்போடுகள் ஏற்படலோம்.மயக்கமருந்து பகோடுக்கப்பட்டவுடன் 
குழந்றதயின்  ோடித்துடிப்பில் தற்கோலிகமோக சில மோற்ைங்கள் ஏற்படலோம்.சில சமயங்களில் 
அறுறவச் சிகிச்றச பசய்ய நவண்டிய அவசியநமோ,ஆயுதம் மூலம் குழந்றதறய எடுக்க நவண்டிய 
அவசியநமோ ஏற்படலோம். இதனோல் உங்களுக்கு உடல் முழுவதும்  சிைிது ந ரத்திற்கு அரிப்பு , 
வோந்தி,குறைந்த இரத்த அழுத்தம் ஏற்படலோம். 
 
ஆய்வில் உங்கள் உரிறமகள்: 
 
உங்கள் மருத்துவ பதிநவடுகள் அந்தரமோக றவத்துக்பகோள்ளப்படும்.இந்த ஆய்வின்  முடிவுகள் 
அைிவியல் பத்திரிக்றககளில் பவளியிடப் படலோம்.ஆனோல் பபயறர பவளியிடுவதன் மூலம்  ீங்கள் 
அறடயோளம் கோட்டப்பட மோட்டீர்கள்.இந்த ஆய்வில் பங்நகற்பது தன்னிச்றசயோனது மற்றும் 
கோரணங்கள் எதுவும் கூைோமநலநய  ீங்கள் எப்நபோது நவண்டுபமன்ைோலும் விலகிக் 
பகோள்ளலோம்.ஏநதனும் பக்க விறளவுகள் ஏற்பட்டோல் முழு சிகிச்றசயும் மருத்துவக்குழுவினரோல் 
உடனடியோக வழங்கப்படும். 
  
                                                                                                                                       
                                                                                                                                    ந ோயோளியின் றகபயோப்பம் 
     ோள்                                                                                                                     
                                                                                                         
  
                                                                                                                                     இடது பபருவிரல் நரறக 
                                            
 
 
 
 
                                                                  (மருத்துவரோல் படித்துக் கோட்டப்பட்டது ) 
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